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Since the observation that nitric oxide (NO) can act as an intercellular messenger in the
brain, the past 25 years have witnessed the steady accumulation of evidence that it acts
pre-synaptically at both glutamatergic and GABAergic synapses to alter release-probability
in synaptic plasticity. NO does so by acting on the synaptic machinery involved in
transmitter release and, in a coordinated fashion, on vesicular recycling mechanisms. In
this review, we examine the body of evidence for NO acting as a retrograde factor at
synapses, and the evidence from in vivo and in vitro studies that specifically establish
NOS1 (neuronal nitric oxide synthase) as the important isoform of NO synthase in this
process. The NOS1 isoform is found at two very different locations and at two different
spatial scales both in the cortex and hippocampus. On the one hand it is located diffusely
in the cytoplasm of a small population of GABAergic neurons and on the other hand the
alpha isoform is located discretely at the post-synaptic density (PSD) in spines of pyramidal
cells. The present evidence is that the number of NOS1 molecules that exist at the PSD
are so low that a spine can only give rise to modest concentrations of NO and therefore
only exert a very local action. The NO receptor guanylate cyclase is located both pre- and
post-synaptically and this suggests a role for NO in the coordination of local pre- and
post-synaptic function during plasticity at individual synapses. Recent evidence shows
that NOS1 is also located post-synaptic to GABAergic synapses and plays a pre-synaptic
role in GABAergic plasticity as well as glutamatergic plasticity. Studies on the function of
NO in plasticity at the cellular level are corroborated by evidence that NO is also involved
in experience-dependent plasticity in the cerebral cortex.
Keywords: LTP (Long Term Potentiation), synaptic plasticity, NOS1, experience-dependent plasticity, guanylate
cyclase
INTRODUCTION
Nitric oxide is a ubiquitous signaling molecule in the brain
and in other organs of the body. It is involved in an almost
bewildering array of functions. Consequently, there have been
many reviews over the years that have described its role in ret-
rograde signaling (Brenman and Bredt, 1997), cellular function
(Garthwaite, 2008), synaptic plasticity (Holscher, 1997), develop-
ment (Contestabile, 2000), excitotoxicity (Calabrese et al., 2007),
blood flow (Gordon et al., 2007) and mental health (Steinert
et al., 2010). However, in this review we focus on the role
of NO in synaptic plasticity and specifically its function as a
retrograde messenger. It seems fitting to look at the evidence
now as it is 25 years since the original discovery that NO (or
endothelial derived relaxing factor) might act as an intercellular
messenger in the brain (Garthwaite et al., 1988), during which
time there has been a steady accumulation of evidence for the
role of NO synthase in synaptic plasticity and homeostasis at
both excitatory and inhibitory synapses. In the following sec-
tions we briefly review the main pathways by which NO acts
and the distance over which it acts, before discussing the evi-
dence for its role in synaptic signaling during plasticity and
homeostasis.
MOLECULAR PATHWAYS FOR THE ACTION OF NO
Nitric oxide is generated by the enzyme NO synthase (NOS).
NOS1 (nNOS or neuronal NOS) is one of three major isoforms
of NO synthase, the others being NOS2 (iNOS or inducible
NOS) and NOS3 (eNOS or endothelial NOS). Many cell types
in the body can express NOS2, including immune response
cells (Hickey, 2001), glial cells (Nomura and Kitamura, 1993)
and neurons (Corsani et al., 2008). Unlike NOS1 and NOS3
that are expressed constitutively, NOS2 is induced by inflam-
matory cytokines (Saha and Pahan, 2006). Calcium/calmodulin
has such a high affinity for NOS2 that its activity is not
modulated by this route, which means that NOS2 activity is
under the control of cytokines rather than calcium signaling.
Antagonists of NOS2 have been reported to reduce synaptic plas-
ticity and alter both spontaneous and evoked synaptic activity
in the cortex (Buskila and Amitai, 2010), although NOS1 may
also have been affected at the drug concentrations used in this
study.
NOS3 was originally isolated from endothelial cells, and along
with other NOS isoforms is present in the tissues of the cardio-
vascular system (Buchwalow et al., 2002). While early reports
suggested NOS3 was located in neurons (Dinerman et al., 1994),
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these findings were later rebutted by the same group (Blackshaw
et al., 2003). NOS1 knockouts show that NOS1 is the source of
95% of the NO in the cortex (Huang et al., 1993) and plays a
major role in synaptic plasticity (see Section NO Controls Pre-
Synaptic Function and The Role of NO in Plasticity). However,
tonic levels of NO produced by NOS3 may also play a role in the
induction of plasticity (Hopper and Garthwaite, 2006).
SOLUBLE GUANYLATE CYCLASE
Soluble guanylyl cyclase (sGC) is the most sensitive receptor for
NO, with an EC50 in the low nanomolar (nM) range (Roy et al.,
2008). A good deal of evidence has been gathered in recent years
for its importance in mediating the actions of endogenous NO,
predominantly at pre-synaptic locations (Garthwaite, 2010; Neitz
et al., 2011; Eguchi et al., 2012; Bartus et al., 2013).
Soluble guanylyl cyclase mediates the production of cGMP
from GTP. Three subunits of the protein have been identified,
α1, α2, and β1. A functional receptor is a heterodimer consist-
ing of one α and one β subunit. Two isoforms of the recep-
tor exist (α1β1 and α2β1) with a complex regional expression.
For example, the α1β1 heteromer is dominant in the caudate-
putamen and nucleus accumbens whilst α2β1 is dominant in the
hippocampus and olfactory bulb (Gibb and Garthwaite, 2001;
Mergia et al., 2003). The α2β1 receptor is present at the high-
est levels in the brain and the α2 subunit has been shown to
bind to the cell membrane through PSD95 (Russwurm et al.,
2001; Mergia et al., 2003), which suggests a post-synaptic local-
ization. The α2β1 isoform can substitute for most functions of
the more widely expressed α1β1 isoform despite there being a
90% reduction in sGC in the α1 KOs (Friebe and Koesling, 2009).
However, deletion of the β1 subunit eliminates expression of any
sGC resulting in an 80% infant mortality within 2 days of birth
(Friebe and Koesling, 2009). To date, the two α subunit isoforms
have only been found to have distinct functions in the induction
of LTP in the visual cortex where both isoforms are necessary
(Haghikia et al., 2007).
The guanylyl cyclase receptor consists of a haem group of the
type that binds O2 in hemoglobin, but when associated with
the receptor protein, it exhibits a substantial preference for NO,
allowing detection of NO in the presence of at least 10,000 fold
excess of O2, despite the molecular similarity of the two ligands
(Martin et al., 2006).
The mechanism of activation of sGC by NO is complex and
involves a conformational change via binding at the haem site,
which enables increased conversion of GTP to cGMP (Roy et al.,
2008). NO activates guanylyl cyclase within 20ms and, following
removal of NO, activity decays with a half life of 200ms (Bellamy
and Garthwaite, 2001). With formation of cGMP, a bifurcation
occurs in the route of action (Figure 1); one route is for cGMP to
affect cGMP-activated protein kinases (cGKs or PKGs). Multiple
substrates for PKG have been identified including PKG activated
phosphatases, leading indirectly to altered levels of phosphoryla-
tion of effector proteins (Schlossmann and Hofmann, 2005). The
second major route of action for cGMP is to bind to agonist or
regulatory sites on cyclic nucleotide-gated (CNG) ion channels or
hyperpolarization-activated, cyclic nucleotide-modulated (HCN)
channels.
FIGURE 1 | Molecular signaling pathways for NO. The main signaling
pathways described in the text for NOS1 are shown together with their
effector molecules. NO has three main routes of action via nitrosothiol
production, cGMP and PKG. Abbreviations: NOS1, Nitric Oxide Synthase 1;
NO, Nitric Oxide; sGC, soluble guanylate cyclase; PKG, protein kinase G;
G-substrate, a phosphatase inhibitor; BKCa, large calcium sensitive
potassium channel; Ca2+N, N-type calcium channel; PIP2,
phosphotidylinositol 4,5 biphosphate; VASP, vasodilator stimulated
phosphoprotien; CNG, cyclic nucleotide gated channel; HCN,
hyperpolarization-activated, cyclic nucleotide-modulated channel; Munc18,
also known as Sec-1, is a pre-synaptic SNARE associated protein; syntaxin
1A, part of the SNARE complex; NR1, NMDA receptor subunit 1; NR2,
NMDA receptor subunit 2; NSF, N-ethylmaleimide sensitive fusion protein.
There is evidence for nitrosothiol production in NSF, NR1, and NR2 in vivo,
but endogenous production of nitrosothiol groups in syntaxin requires
confirmation.
PRODUCTION OF NITROSOTHIOL GROUPS
There are a number of cases where NO signaling in the brain is
transduced in a cGMP independent manner. The thiol side chains
of cysteine residues in proteins can be modified by the addition
of an NO group and this outcome could occur by two known
routes: the thiol group can be oxidized to a thyl followed by addi-
tion of NO, which is known as oxidative nitrosylation, or NO can
react with O2 to produce N2O3 which then interacts with the thiol
group to produce nitrosothiol, and this process is known as nitro-
sation (Heinrich et al., 2013). At present, the endogenous route
for nitrosothiol production is not known.
A number of pre-synaptic proteins have been identified as
potential targets for nitrosothiol production and therefore as a
mechanism for mediating alterations in pre-synaptic strength
(Figure 1). The t-snare protein synapsin has been identified as a
target for nitrosothiol production in pancreatic cells (Wiseman
et al., 2011) and syntaxin 1a and n-sec1 (also known as Munc18)
have been shown to be a target for nitrosothiol production in
neurons (Meffert et al., 1996; Prior and Clague, 2000; Palmer
et al., 2008). A small GTPase known as Dexras1 (which can be
induced by dexamethasone) is held in close proximity to NOS1 by
CAPON (Jaffrey et al., 1998) and can be modified by production
of nitrosothiol (Fang et al., 2000).
Nitrosothiol production requires much higher concentrations
of NO than activation of sGC and proceeds with slower kinet-
ics. For example, nitrosothiol production in syntaxin 1A occurs
with an IC50 of 1.1μM NO (Palmer et al., 2008) compared with
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the nM range of detection for sGC (Roy et al., 2008). It has been
estimated that an NO concentration of 200μM would require
2min to produce nitrosothiol groups in half the substrate (Ahern
et al., 2002). The high concentrations and slow reaction kinetics
of nitrosothiol production raise the question of whether it can
occur naturally. Most of the experiments conducted on produc-
tion of nitrosothiol groups in various proteins use NO donors
at quite high levels [for example 100–1000μM for nitrosothiol
production in SNAP25 (Di Stasi et al., 2002)]. However, a tech-
nique for detecting nitrosothiol groups in proteins known as the
biotin switch method has been used to demonstrate the existence
of endogenous nitrosothiol groups in vivo by comparing results
in wild-type mice with NOS1 knockout mice (Jaffrey et al., 2001).
The synaptic proteins that appear to have endogenous nitrosoth-
iol groups using this method include NR1, NR2A (Jaffrey et al.,
2001), and NSF (Huang et al., 2005).
It may not be coincidental that some of the molecules shown
to have nitrosothiol groups in vivo are held in close proximity to
NOS1 and thereby experience the higher source concentrations
of NO. The NMDA receptor is local to NOS1 by virtue of them
both binding to PSD95 and dexras1 is close to NOS1 because both
bind to CAPON (Fang et al., 2000). It may also be relevant that
nitrosothiol groups occur on molecules that tend to lie close to
lipid membranes, in this case synaptic membranes. It has been
suggested that the kinetics of the reaction between NO and O2 to
produce N2O3 could be increased by NO and O2 becoming con-
centrated in lipid membranes (Heinrich et al., 2013). However,
once again it should be emphasized that the endogenous routes
for generating nitrosothiol groups on proteins are not known at
present.
THE CELLULAR LOCATION OF NOS1
NOS1 is composed of several splice variants. The long form
of NOS is αNOS1 which contains a PDZ binding domain that
enables it to bind to the PDZ2 domain of PSD95 (Brenman et al.,
1996; Eliasson et al., 1997) localizing NOS1 to the post-synaptic
density (see Doucet et al., 2012). There are also shorter splice
variants of NOS1 lacking the PDZ domain known as βNOS1 and
γNOS1. While the latter is not expressed very highly in the brain,
βNOS1 is expressed quite highly in the ventral cochlear nuclei, the
striatum and the lateral tegmental nuclei (Eliasson et al., 1997). In
the cortex and hippocampus, the current evidence suggests that
NOS1 is located in two very different neuronal compartments
in two different cell types. On the one hand, NOS1 is located in
the cytoplasm of a small subpopulation of GABAergic cells in the
cortex and hippocampus and on the other, it is located in a far
larger population of excitatory neurons, but highly restricted to
the spine head. The ease with which NOS1 can be detected at
the two locations depends on the techniques used as described
below.
LIGHT MICROSCOPY
The light microscopy (LM) level is sufficient to demonstrate the
presence of cytoplasmic NOS1 (Eliasson et al., 1997; Blackshaw
et al., 2003; Kubota et al., 2011). LM antibody studies have
shown that the strongest NOS1 staining in the neocortex and hip-
pocampus occurs in a small subpopulation of GABAergic neurons
(Wendland et al., 1994; Aoki et al., 1997; Blackshaw et al., 2003)
that co-express Somatostatin, Neuropeptide Y and the Substance
P receptor (Kubota et al., 2011). The NOS1+ GABAergic neu-
rons contain both αNOS1 and βNOS1. A significant component
of the cytoplasmic staining is attributable to βNOS1 as it per-
sists in αNOS1 knockouts (Eliasson et al., 1997). Weaker labeling
of the cortical neuropil is also consistently reported in the same
papers. Recent studies using targeted knockin of cre-recombinase
into the NOS1 gene and subsequent crosses to GFP reporter lines
clearly show two populations of NOS1+ GABAergic cells, one
of neurogliaform morphology (type II) and the other character-
ized by long range axonal projections (type I) (Taniguchi et al.,
2011). Again the neuropil can be seen throughout the cortical
layers including clear axonal labeling (Figure 2). Pyramidal cell
labeling is not seen in these cre lines, however, possibly due to
the technique only showing high levels of NOS1 expression (Josh
Huang personal communication). Weak labeling of CA1 pyra-
midal cells can be seen using NOS1 antibodies with the right
fixative conditions (Burette et al., 2002; Blackshaw et al., 2003)
and colocalization of NMDA, PSD95, and NOS1 shows that some
of the punctate labeling seen with LM is due to NOS1 in spines
(Burette et al., 2002).
ELECTRON MICROSCOPY
Using electron microscopy (EM), much of the neuropil label-
ing present in LM studies can be seen to reside in the axons of
NOS+ GABAergic neurons (Aoki et al., 1997). However, EM stud-
ies reveal a further component of the neuropil labeling to be due
to the very precise and restricted localization of NOS1 in spines,
spine heads, and occasionally the plasma membrane of dendrites
FIGURE 2 | NOS1 positive cells at the LM level in the Cortex and
Hippocampus. Cells expressing TdTomato fluoresce in nNOS positive cells
in an nNOS-CreER;Ai9 mouse. The TdTomato is rendered green in the
images. (A) The nNOS positive cells make up a small population scattered
in cortex and hippocampus. (B) A dense and diffuse plexus of neuropil can
be seen throughout layer II/III and (C) throughout deeper layers of the
cortex. Single arrows indicate axons and double arrows dendrites. Adapted
from Taniguchi et al. (2011) with kind permission of the authors and Cell
press.
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(Aoki et al., 1997, 1998). The NOS1 visible in the heads of spines
in the visual cortex and in some cases at the base of spines
accounts for 30–75% of the punctate labeling in cortical elec-
tron micrographs (Figure 3). Although the NOS1+ GABAergic
neurons are sparsely spiny and could theoretically account for
some of the NOS1 spine labeling, the extent of the spine label-
ing seen in EM is too great to be due purely to GABAergic cells
(Cheri Aoki personal communication); therefore a considerable
amount of spine labeling must be attributable to excitatory pyra-
midal cells. Furthermore, the NOS1 labeling in spines is quite
distinctive in that the labeled spines are joined to dendrites that
do not contain NOS1 labeling (Figure 3); if these spines were
located on GABAergic cells, the cytoplasm would be labeled as
well. EM studies of cortical synapses also show that the gold parti-
cle distribution associated with NOS1 labeling is coextensive with
that for PSD95 relative to the plasma membrane (Valtschanoff
and Weinberg, 2001). Similarly, in the hippocampus, EM stud-
ies show that NOS1 is located in dendritic spines on pyramidal
cells (Burette et al., 2002). The NO receptor sGC is found pre-
synaptic and within 50–150 nm of the NOS (Figure 4). In conclu-
sion, pyramidal cells in the neocortex and hippocampus contain
NOS1 that is highly localized to the spine head, spine neck, or
plasma membrane of the dendrites and is closely apposed to pre-
synaptic sGC.
MOLECULAR AND FUNCTIONAL METHODS
The reason why NOS1 is localized to the spine head is due to the
nature of the alpha sub-isoform of NOS1 which contains a PDZ
binding domain that enables it to bind to the PDZ2 domain of
PSD95 (Brenman et al., 1996; Eliasson et al., 1997). Using pro-
teomic analysis of molecules associated with the NMDA receptor,
it has been shown that NOS1 is part of the NMDA signaling
complex (Husi et al., 2000). The authors used a combination of
immunoaffinity chromatography, immunoprecipitation with an
antibody directed against the NR1 subunit, and peptide affinity
based on the structure of the NR2B subunit C terminus that binds
to the NMDAR-binding protein PSD-95. The structure and bind-
ing partners of NOS1 and PSD95 are reviewed in (Zhou and Zhu,
2009) and (Doucet et al., 2012).
Functional assays also demonstrate the synaptic location of
NOS1. The functional consequences of disrupting the interac-
tion between NOS1 and PSD95 has been studied by express-
ing decoy proteins that code for amino acids constituting
the PDZ binding domain of αNOS1. For example, glutamate
induced activation of p38 normally leads to excitotoxic cell
death, but this process can be prevented by expression of
the first 300 amino acids of NOS1 (NOS11–300) (Cao et al.,
2005). Similarly, cerebral ischemia induced by cerebral artery
occlusion leads to cortical damage which can be reduced by
FIGURE 3 | NOS1 positive spines at the EM level in the Visual Cortex. (A)
Large dendritic spine (S1) with a perforated PSD showing
NOS1-immunoreactivity (arrowheads). NOS1 immunoreactivity is also present
along the plasma membrane (small arrow) and near the spine apparatus (sa). A
second small spine (S2) shows NOS1 immunoreactivity along the plasma
membrane and over the PSD. Not all spines are labeled (S3 and S4). T
represents unlabeled pre-synaptic terminals. Open arrows mark unlabeled
PSDs. (B) Axodendritic synapse showing NOS1 labeling of a PSD (arrowhead).
(C) NOS1 labeling occurs at the spine base (upper curved arrow) and dendritic
shaft (small arrows). Lower curved arrow points to an unlabeled spine. S is a
spine head and D is a dendritic shaft where limited NOS1 labeling occurs along
the plasma membrane. (D) NOS1 immunoreactivity over the spine neck (S),
plasma membrane forming the spine head (small arrow) and the PSD (filled
arrowhead). US marks an unlabeled spine and open arrowheads also mark
unlabeled spines and T is the pre-synaptic terminal. (E)NOS1 immunoreactivity
only in the spine head. Note that in all these cases there is no labeling of the
dendritic cytoplasm. Calibration bar = 500 nm. Adapted from Aoki et al. (1998)
with kind permission of the author and Elsevier press.
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FIGURE 4 | NOS1 positive spines and sGC positive terminals in the
hippocampus. (A) Positions of gold particles identifying NOSI and sGC
located within 150 nm of the post-synaptic membrane. Inset, labeling close
to the plasma membrane is concentrated at the synaptic specialization for
both antigens. (B) Double immunogold labeling showing that NOS1-positive
PSDs lie post-synaptic to sGC-positive axon terminals. Small dots are 5 nm
gold particles labeling NOS1. Large dots are 10 nm gold particles labeling
sGCβ. Scale bar is 200 nm. Adapted from Burette et al. (2002) with kind
permission of the authors and the Society for Neuroscience.
NOS11–133 (Zhou et al., 2010) and pTAT-PDZ1-2 (Aarts et al.,
2002). Thermal hyperalgesia and chronic mechanical allody-
nia can be inhibited by intrathecal application of IC8731 or
tat-NOS1 (NOS1 1-299) (Florio et al., 2009). These molecules
do not act to reduce the enzymatic activity of NOS1, but
rather to decrease the coupling between NOS1 and NMDA
receptors by disrupting the ability of NOS1 to bind to PSD95
(Florio et al., 2009).
Finally, studies on synaptic plasticity (as described in Section
The Role of NO in Plasticity), show that the pre-synaptic NO-
dependent component of LTP can be prevented by post-synaptic
application of NOS antagonists to layer 2/3 pyramidal cells in
the somatosensory cortex (Hardingham and Fox, 2006). Similar
results have been demonstrated for layer 5 cortical cells (Sjostrom
et al., 2007). This implies that the NO synthase exists in pyramidal
cells in the cortex.
In conclusion, LM studies are able to demonstrate the presence
of NOS1 in the NOS+ GABAergic cells of the neocortex and hip-
pocampus but LM is at the limit for demonstrating its presence in
pyramidal cells, while EM, proteomic, and functional analysis are
sensitive enough to demonstrate the presence of NOS1 at spines
of pyramidal cells.
THE PHYSIOLOGICAL CONCENTRATION OF NO AND ITS
DISTANCE OF ACTION
A theoretical consideration of the rate of production of NO at
an individual synapse suggests that NO has a source concen-
tration in the low nanomolar range. Working forward from a
knowledge of the rate of NO production per NOS molecule
in vitro of 20 per second (Santolini et al., 2001) and using an
estimate of the number of NMDA receptors and therefore NOS
molecules present at a single post-synaptic density, the concen-
tration in the immediate vicinity of the NOS molecule can be
estimated at 2.5 nM, falling 10 fold within approximately 700 nm
(Hall and Garthwaite, 2009). Working backwards from a measure
of NO concentration generated in a cerebellar slice stimulated
with NMDA gives a similar rate of production of NO per NOS
molecule (10 per second) and a source concentration at the
synapse of approximately 0.01–0.1 nM (Wood et al., 2011). A
number of studies have reported that NO is produced in the brain
in the picomolar range (Wakatsuki et al., 1998; Sato et al., 2006;
Wood et al., 2011) and several other labs in the low nM range
(<10 nM) (Shibuki and Kimura, 1997; Kimura et al., 1998; Wu
et al., 2001, 2002; Sammut et al., 2006, 2007a,b; Ondracek et al.,
2008; Sammut and West, 2008).
If the concentration of NO produced at a synapse is in the pM
to lownM range, then the rate of inactivation of NO with dis-
tance in the brain implies that it can only act over a relatively
short range. The most sensitive target for NO is soluble guany-
late cyclase (sGC), which can respond to as little as 1 pM NO
(Batchelor et al., 2010). The EC50 of sGC to NO is thought to
be in the low nanomolar range at 1.7 nM (Griffiths et al., 2003).
Physiological concentrations of ATP (1mM) and GTP (0.1mM),
which antagonistically decrease and increase the sensitivity of sGC
to NO, respectively, elevate the EC50 to 3.4 nM (Roy et al., 2008).
Taking into account both the likely concentration of NO at the
synapses and the sensitivity of sGC suggests that NO is only likely
to act over distances of less than 1 micron.
The lower estimate of NO evolution in the picomolar range
would sit on the non-linear cusp of the NO/sGC binding curve
(Roy et al., 2008). This raises the interesting possibility that a tonic
level of NO production could interact with the NMDA recep-
tor activated NO concentration to boost its effect on sGC. For
example, a tonic level of 250 pM NO would move the operat-
ing point of the synapse onto the linear part of the NO/sGC
curve [see Figure 7B of Roy et al. (2008)]. There is evidence for
a tonic level of NO production in the brain originating from both
NOS3 and NOS1 (Hopper and Garthwaite, 2006; Dachtler et al.,
2011). Furthermore, tonic levels of NO have been found to influ-
ence the magnitude of LTP, giving further credence to this notion.
NO donors can be shown to facilitate both post-synaptic poten-
tials and LTP (Bohme et al., 1991; Malen and Chapman, 1997;
Hardingham and Fox, 2006). The higher estimate of NO release
in the nM range would not require background levels of NO to
move sGC on to the linear part of its response curve. With either
mode of action, NO would only be able to act over a distance of
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less than about 1 micron, effectively making it a synapse specific
signal.
The view of NO as a synapse specific signal does not fit with the
notion of NO as a volume transmitter. Nevertheless, there is evi-
dence for NO acting as a volume transmitter in the Calyx of Held
(Steinert et al., 2008). Theoretically, all that would be required
for higher concentrations of NO would be higher concentra-
tions of the enzyme NOS. It is conceivable that the GABAergic
inhibitory cells that express NOS1 at much higher levels than
excitatory cells (Figure 2) throughout their cytoplasm could pro-
vide such a source. The NOS1+ GABAergic cells produce a plexus
of fine NOS positive fibers that ramify throughout the cortex
and hippocampus, which could aid spatial summation of NO
levels. However, little is known of NO release from this small
subpopulation of cells at present.
NO CONTROLS PRE-SYNAPTIC FUNCTION
The past two decades have seen a steady but decisive accumulation
of evidence showing not only that NO acts pre-synaptically on
neurotransmitter release, but how it does so (Feil and Kleppisch,
2008). Table 1 is a compilation of papers showing some of the
evidence for NO’s pre-synaptic action, its retrograde route from
post- to pre-synaptic site and its pre-synaptic action in plasticity.
Much of the detailed evidence for NO’s role in transmit-
ter release comes from studies on the glutamatergic system,
but a body of work implicates NO in regulating transmitter
release from GABAergic (Kawaguchi et al., 1997; Li et al., 2002;
Moreno-Lopez et al., 2002; Wall, 2003; Szabadits et al., 2007; Yang
et al., 2007; Bright and Brickley, 2008; Xue et al., 2011; Lange
et al., 2012) dopaminergic (West et al., 2002) and noradrenergic
synapses (Montague et al., 1994; Kodama and Koyama, 2006).
A number of the studies providing evidence for the retrograde
action of NO have come from cell cultures. Cell culture prepa-
rations have a number of technical advantages that allow the
retrograde action of NO to be demonstrated (Table 1). However,
since cells in culture are immature, it raises the question of
whether NO acts the same way inmoremature cells. Nevertheless,
a number of studies made on mature neurons in intact slices
of hippocampus (O’Dell et al., 1991; Schuman and Madison,
1991), amygdala (Lange et al., 2012), neocortex (Hardingham
and Fox, 2006; Sjostrom et al., 2007), the medial nucleus of the
trapezoid body (Steinert et al., 2008; Eguchi et al., 2012), cere-
bellum (Qiu and Knopfel, 2007), and the ventral lateral medulla
(Huang et al., 2003), lead to similar conclusions about the action
of NO in mature cells, suggesting that NO retains its retrograde
pre-synaptic action into adulthood.
In the following sections we briefly review the findings for
NO’s effects on four aspects of pre-synaptic function; actions
at the active zone, on vesicle recycling, effects on the readily
releasable pool and actions on pre-synaptic growth. When viewed
in combination, these studies suggest that NO may regulate pre-
synaptic release by acting in a coordinated and synergistic manner
on several aspects of pre-synaptic release (Figure 5).
EFFECTS ON THE ACTIVE ZONE AND TRANSMITTER RELEASE
Nitric oxide can affect transmitter release by nitrosothiol genera-
tion in a number of constituents of the active zone (Figure 5B).
For example, nitrosothiol production in syntaxin at Cys(145) has
a facilitatory effect on release because it prevents munc18 (also
known as n-sec1) from binding to the closed conformation of
syntaxin 1a. This allows syntaxin1a to unfold and bind to both
VAMP on the vesicle and SNAP25 at the release site, which in
turn enables the vesicle to dock to the membrane (Meffert et al.,
1996; Palmer et al., 2008). SNAP25 can itself have nitrosothiol
groups generated by NO, which may further enhance release (Di
Stasi et al., 2002). However, it is not clear at present whether
the concentrations of NO necessary for production of nitrosoth-
iol groups are realized at the synapse (see Sections The Cellular
Location of NOS1 and The Physiological Concentration of NO
and Its Distance of Action).
EFFECTS ON ION CHANNELS
Voltage gated ion channels that reside in the pre-synaptic ter-
minal and affect transmitter release have been shown to be NO
sensitive. In the peptidergic synapse of the pituitary nerve, NO
can increase pre-synaptic release by enhancing the activity of
large conductance Ca2+ activated K+ channels (BK). PKG only
activates BK at depolarized potentials, which means that the
action potential after-hyperpolarization becomes larger without
affecting the spike threshold. Consequently, during prolonged
trains of action potentials, the enhanced hyperpolarization pro-
vided by BK channels accelerates Na+ channel recovery (Klyachko
et al., 2001). It can be demonstrated that cytosolic calcium
almost doubles in the presence of exogenous cGMP. A possi-
ble physiological role for this action is suggested by showing
that the action potential success rate during a 25Hz stimulus
train is almost twice as great in the control condition when
compared to that in the presence of the NO synthase inhibitor
7-NI or the sGC inhibitor ODQ (Klyachko et al., 2001). In
the brainstem, synaptic potentials generated by glutamatergic
synapses in the ventrolateral medulla can be enhanced by appli-
cation of the NOS substrate L-arginine (200 uM) (Huang et al.,
2003). This effect can be shown to be due to NO acting via a
cGMP/protein kinase G-dependent pathway on N-type calcium
channels (Huang et al., 2003). It is not known at present whether
BK or N-type calcium channels are affected by NO in the cortex
or hippocampus.
One other means by which NO may affect transmitter release
in some types of neuron is by stimulating the production of
cGMP, which directly gates cyclic nucleotide gated channels
(Neitz et al., 2011). Cyclic nucleotide gated (CNG) channels are
well known for their function in transmitter release in some
classes of cell, for example photoreceptors (Rieke and Schwartz,
1994) and olfactory epithelial cells (Leinders-Zufall et al., 2007).
However, the distribution of CNG channels is more widespread
and roughly mirrors the distribution of the NO/cGMP sys-
tem (Kingston et al., 1999). For example, CNG channels are
present in the rat hippocampus (Kingston et al., 1999) and
may be involved in the induction of theta burst LTP in mouse
hippocampus (Parent et al., 1998). While native heteromeric
CNG channels formed by alpha and beta subunits are gated by
cGMP, homomeric channels comprising just the beta subunit
are directly activated by NO (Broillet and Firestein, 1997), rais-
ing the possibility that NO might act on native CNG channels
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Table 1 | Evidence that nitric oxide influences presynaptic function.
References Title Presynaptic
action?
Retrograde
messenger?
Effect on
plasticity?
Transmitter Structure
(preparation)
Arancio et al., 1996a Nitric oxide acts directly in
the presynaptic neuron to
produce long-term
potentiation in cultured
hippocampal neurons
   Glutamate Hippocampus
(cell culture)
Lange et al., 2012 Heterosynaptic long-term
potentiation at
interneuron-principal neuron
synapses in the amygdala
requires nitric oxide signaling
   GABA Amygdala
(slices)
O’Dell et al., 1991 Tests of the roles of two
diffusible substances in
long-term potentiation:
evidence for nitric oxide as a
possible early retrograde
messenger
   Glutamate Hippocampus
(slices)
Sjostrom et al., 2007 Multiple forms of long-term
plasticity at unitary
neocortical layer 5 synapses
   Glutamate Visual cortex
(slices)
Hardingham and Fox, 2006 The role of nitric oxide and
GluR1 in presynaptic and
postsynaptic components of
neocortical potentiation
   Glutamate Barrel cortex
(slices)
Schuman and Madison, 1991 A requirement for the
intercellular messenger nitric
oxide in long-term
potentiation
   Glutamate Hippocampus
(slices)
Volgushev et al., 2000 Retrograde signaling with
nitric oxide at neocortical
synapses
   Glutamate Visual cortex
(slices)
Montague et al., 1994 Role of NO production in
NMDA receptor-mediated
neuro-transmitter release in
cerebral cortex
  Glutamate Neocortex
(synaptosomes)
Micheva et al., 2003 Retrograde regulation of
synaptic vesicle endocytosis
and recycling
  Glutamate Hippocampus
(cell culture)
Eguchi et al., 2012 Maturation of a
PKG-dependent retrograde
mechanism for exoendocytic
coupling of synaptic vesicles
  Glutamate MNTB/Caylx of
Held (slices)
Lindskog et al., 2010 Postsynaptic GluA1 enables
acute retrograde
enhancement of presynaptic
function to coordinate
adaptation to synaptic
inactivity
  Glutamate Hippocampus
(cell culture)
(Continued)
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Table 1 | Continued
Qiu and Knopfel, 2007 An NMDA receptor/nitric
oxide cascade in presynaptic
parallel fiber-Purkinje neuron
long-term potentiation
  Glutamate Cerebellum
(slices)
Johnstone and Raymond, 2011 A protein synthesis and nitric
oxide-dependent presynaptic
enhancement in persistent
forms of long-term
potentiation
  Glutamate Hippocampus
(slices)
Stanton et al., 2005 Imaging LTP of presynaptic
release of FM1-43 from the
rapidly recycling vesicle pool
of Schaffer collateral-CA1
synapses in rat hippocampal
slices
  Glutamate Hippocampus
(slices)
Wang et al., 2005 Presynaptic and postsynaptic
roles of NO, cGK, and RhoA
in long-lasting potentiation
and aggregation of synaptic
proteins
  Glutamate Hippocampus
(cell culture)
Arancio et al., 2001 Presynaptic role of
cGMP-dependent protein
kinase during long-lasting
potentiation
  Glutamate Hippocampus
(cell culture)
Huang et al., 2003 cGMP/protein kinase
G-dependent potentiation of
glutamatergic transmission
induced by nitric oxide in
immature rat rostral
ventrolateral medulla neurons
in vitro
 Glutamate Ventrolateral
medulla (slices)
Ratnayaka et al., 2012 Recruitment of resting
vesicles into recycling pools
supports NMDA
receptor-dependent synaptic
potentiation in cultured
hippocampal neurons
 Glutamate Hippocampus
(cell culture)
Neitz et al., 2011 Presynaptic nitric oxide/
cGMP facilitates glutamate
release via
hyperpolarization-activated
cyclic nucleotide-gated
channels in the hippocampus
 Glutamate Hippocampus
(slices)
by two routes. Finally, at the glutamatergic neuromuscular junc-
tion in Drosophila, calcium independent vesicular release can
result from cGMP triggered by NO (Wildemann and Bicker,
1999), although the exact downstream processes by which this
occurs are not known. Calcium independent vesicular release can
also be observed in hippocampal synaptosomes (Meffert et al.,
1994).
EFFECTS ON VESICLE RECYCLING
In order to sustain synaptic release over a period of time, the
rate of vesicle recycling needs to at least equal the rate of vesi-
cle exocytosis. This issue is particularly problematic for synapses
that release transmitter at high rates, such as those located at
the Calyx of Held that terminate on neurons of the medial
nucleus of the trapezoid body (MNTB). Part of the solution to
Frontiers in Cellular Neuroscience www.frontiersin.org October 2013 | Volume 7 | Article 190 | 8
Hardingham et al. Nitric oxide and pre-synaptic plasticity
FIGURE 5 | Effects of NO on the pre-synaptic terminal. (A) NO affects
release-probability most likely through a combination of effects including
enhancing N-type calcium channel conductance via PKG, increasing the
rate of endocytosis and vesicle recycling as well as altering the balance of
the readily releasable pool via PKG and PIP2. By acting on BK channels, the
probability of action potential failures during moderate spike rates is
reduced (see text for the related references). (B) There is evidence that
many of the SNARE proteins are affected by NO. Syntaxin 1A and SNAP25
can have nitrosothiol groups added although whether this happens at
physiological NO concentrations is yet to be established. NO also creates
nitrosothiol groups on Munc18 and thereby disinhibits syntaxin from
forming the SNARE complex. Alpha Synuclein is also affected by NO
signaling. Synaptobrevin is not known to be affected by NO.
this problem at the Calyx is provided by linking vesicle recy-
cling to retrograde release of post-synaptic NO. Activation of
the post synaptic MNTB neurons is related to the level of NO
production (Steinert et al., 2008), which then drives the level of
pre-synaptic cGMP production and hence the level of PKG activ-
ity (Eguchi et al., 2012). Finally, activation of PKG up-regulates
PIP2, which increases the rate of endocytosis (Eguchi et al., 2012).
This homeostatic mechanism therefore links pre-synaptic rate of
release (which is sensed by post-synaptic NOS1) to the rate of
pre-synaptic vesicle recycling (Figure 5). Regulation of the recy-
cling rate has also been demonstrated in the hippocampus, where
a very similar retrograde NO—pre-synaptic cGMP/PIP2 cascade
regulates the rate of endocytosis and recycling (Micheva et al.,
2003).
EFFECTS ON AVAILABILITY AND SIZE OF THE READILY RELEASABLE
POOL (RRP)
Studies aimed at investigating the nature of synaptic plastic-
ity have shown that LTP is accompanied by an increase (and
LTD a decrease) in the rate of vesicular release from the read-
ily releasable pool (RRP). The LTP process is NMDA receptor-,
tyrosine kinase- and NO-dependent while the LTD process is
NMDA-, NO- and PKG-dependent (Stanton et al., 2003, 2005).
Studies have shown that the size of the RRP can be modulated by
NO (Figure 5). For example, in the case of LTP, NMDA receptor
activation leads to NO and calcineurin activation, which com-
bine to increase the proportion of vesicles available for release
(i.e., increase the RRP) (Ratnayaka et al., 2012). Once again this
can be seen as a homeostatic response to an increase in release
probability brought about by the process of LTP itself. The two
processes are coordinated because NO is involved both in increas-
ing transmitter release and increasing the size of the readily
releasable pool.
EFFECTS ON GROWTH OF PRE-SYNAPTIC TERMINALS
Nitric oxide also affects the growth and formation of new pre-
synaptic terminals and can lead to the formation of multi-
innervated spines. Long lasting potentiation leads to an increase
in pre- and post-synaptic proteins in hippocampal cell cultures.
GluA1 subunits of the AMPA receptor increase post-synaptically
and synaptophysin increases pre-synaptically (Antonova et al.,
2001). Furthermore, the two synaptic markers co-localize at
higher frequency following long lasting potentiation, indicat-
ing that new synapses are formed. It has been shown that
NMDA receptors, NO and actin are required for the pre-synaptic
changes. NO acts via PKG to phosphorylate VASP (which acts on
actin) and also via cGMP to act in parallel and downstream of
RhoGTPase (Wang et al., 2005).
Further evidence for the role of NO in pre-synaptic growth
comes from studies manipulating the PDZ2 domain of PSD95
(which is the PDZ domain that binds NOS1). Up-regulation of
PSD95 in cultured hippocampal neurons or treatment with an
NO donor leads to the formation of multi-innervated spines
(MIS). However, if the PDZ2 domain on PSD95 is deleted,
thereby dissociating NOS1 from PSD95, multi-innervated spines
fail to form (Nikonenko et al., 2008). Similarly, down regulat-
ing NOS1 expression with iRNA also prevents MIS from forming
(Nikonenko et al., 2008). Finally, increasing SAP97 expression
leads to an increase in PSD95 and again an increase inMIS (Poglia
et al., 2011). This effect is blocked by NOS antagonists (Poglia
et al., 2011).
In conclusion, the studies cited above show that NO is not only
involved in the relatively short term changes involved in trans-
mitter release, such as recycling rates and availability of vesicles,
but also, in the long-term, in increasing the availability of trans-
mitter by formation of new pre-synaptic terminals, which results
in dendritic spines receiving extra pre-synaptic terminals. Such
processes could find application in synaptic plasticity. In the fol-
lowing section we review the function of NO in plasticity and
examine to what extent the retrograde route of action is involved.
THE ROLE OF NO IN PLASTICITY
NO-DEPENDENT PRE-SYNAPTIC PLASTICITY
Some of the earliest studies on the role of NO in synaptic plas-
ticity indicated that it might act at a pre-synaptic locus (O’Dell
et al., 1991). Exogenous NO applied to neurons in a hippocampal
slice increased spontaneous mini EPSCs and hemoglobin act-
ing as an extracellular scavenger for NO was found to prevent
LTP (O’Dell et al., 1991). Indeed, initial studies on the mech-
anisms of LTP itself provided evidence for a pre-synaptic locus
of LTP expression (Malinow and Tsien, 1990). In a series of
experiments on cultured hippocampal neurons, Arancio and col-
leagues showed that cGMP (the downstream effector of NO)
needs to be pre-synaptic and NOS post-synaptic to produce
plasticity. First, cGMP causes an increase in EPSC amplitude
when injected into the pre-synaptic but not the post-synaptic cell
(Arancio et al., 1995). Second, application of a PKG antagonist
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peptide blocks tetanus induced LTP when injected into the
pre-synaptic but not the post-synaptic neuron (Arancio et al.,
2001). Third, application of a cGMP analogue increases miniature
EPSC frequency and this effect is blocked by a post-synaptically
but not pre-synaptically injected NOS inhibitor (Arancio et al.,
1996a). Forth, a pre-synaptic injection of an NO scavenger also
abolishes LTP (Arancio et al., 1996b). More recent work employ-
ing fluorescent markers of pre-synaptic function have visual-
ized the pre-synaptic effect of NO in potentiation. Fluorescence
imaging of FM-styryl dyes and synaptophysinI-pHluorin has
shown that increases to the pre-synaptic recycling pool frac-
tion following synaptic strengthening are dependent upon both
NMDA receptor activation and NO release (Ratnayaka et al.,
2012).
THE EFFECT OF INITIAL RELEASE-PROBABILITY ON THE LOCUS OF
PLASTICITY
Early studies on hippocampal plasticity showed that the ini-
tial release-probability of the synapse influences whether a pre-
or post-synaptic change occurs following LTP (Larkman et al.,
1992). If the release-probability of the synapse is low initially
then pre-synaptic plasticity occurs, whereas if the pre-synaptic
release-probability is high, then a post-synaptic change occurs
(Larkman et al., 1992). A similar principal operates at neocorti-
cal synapses. In visual cortex, the initial release-probability of the
synapse, as judged by the paired pulse ratio (PPR), is predictive of
whether NO-dependent potentiation occurs. Using a purely post-
synaptic tetanus (without intentionally eliciting action potentials
in the pre-synaptic terminals), potentiation occurs in synapses
with a low initial PPR and depression or no change occurs in
synapses with a high initial PPR (Volgushev et al., 2000). The
same conclusion is arrived at if a paired pre- and post-spike
conditioning protocol is used. Low release-probability synapses
potentiate via changes in release-probability and high release-
probability synapses depress (Hardingham et al., 2007). This nor-
malization process causes the population of connections to adopt
a more homogenous set of release probabilities after the proto-
col. These studies lead to two important conclusions; first, the
direction of pre-synaptic plasticity acts in a homeostatic manner
to move release-probability to an intermediate value and second,
that pre-synaptic plasticity occurs provided that there is sufficient
dynamic range for it to occur. There is less scope for increas-
ing release-probability at a high release-probability synapse than
at a low release-probability synapse. Potentially, a high release-
probability synapse could show pre-synaptic potentiation by
growth and/or production of MIS, which can occur and is NO-
dependent (section Effects onGrowth of Pre-Synaptic Terminals),
but structural changes are unlikely within the timescale of an LTP
experiment.
Since the initial release-probability of the synapse is an impor-
tant determinant of the locus of plasticity and in which direction
it operates, factors that control initial release-probability will
determine the level and form of pre-synaptic plasticity. Adenosine
is known to affect release-probability (Prince and Stevens, 1992)
and a recent study in layer 5 of the somatosensory cortex has
shown that adenosine levels are low early in development (P11-
P22) and higher in older animals (P28-32) (Kerr et al., 2013).
This maturational change means that adenosine reduces release-
probability in older animals, thereby increasing the dynamic
range for pre-synaptic potentiation. Some mutant mice strains
have unusually low initial release-probability synapses that can
provide an increased dynamic range for LTP. For example, H-
RasG12V mice have low release-probability synapses in the visual
cortex, as judged by short-term dynamics and mini EPSP fre-
quency, and consequently enhanced LTP with an increased pre-
synaptic component (Kaneko et al., 2010).
PRE- AND POST-SYNAPTIC COMPONENTS OF PLASTICITY
Early studies on the role of NO in LTP using NO antagonists
often found an absolute requirement for NO (Bohme et al.,
1991; O’Dell et al., 1991; Schuman and Madison, 1991; Haley
et al., 1993; Doyle et al., 1996; Malen and Chapman, 1997),
whereas more recent studies have found LTP to be reduced rather
than abolished in the absence of NO, both in the hippocampus
(Phillips et al., 2008) and in the neocortex (Hardingham and Fox,
2006).
In the neocortex, LTP occurs as a mixture of pre- and
post-synaptic changes, but the two components can be dis-
sociated, either by blocking NOS post-synaptically or knock-
ing out GluA1 (Hardingham and Fox, 2006). When a NOS
inhibitor is introduced to the post-synaptic neuron via the
electrode, plasticity proceeds by changes in quantal amplitude
without changes in the variance of the response amplitude
(Hardingham and Fox, 2006). Similarly, where single or double
quantal release peaks are isolated in layer 2/3 neuones, LTP occurs
by changing the quantal amplitude without changes in release-
probability (Figure 6). Conversely, in GluA1 knockouts, LTP
results in changes in release-probability (NPr) without changes
in quantal amplitude (Q) (Hardingham and Fox, 2006). Given
that potentiation is NO-dependent in GluA1 knockouts this
implies that NO acts via a pre-synaptic mechanism in neocortex
(Hardingham and Fox, 2006).
The situation is similar in the mature hippocampus, in that
the plasticity present in the GluA1 knockouts is largely NO-
dependent (Phillips et al., 2008; Romberg et al., 2009), but it is
not clear in this case whether the locus of NO-dependent plas-
ticity is pre- or post-synaptic, or perhaps both. Phillips et al.
(2008) suggested a pre-synaptic origin for NO-dependent LTP
based on the decrease in PPR for 14/21 cases following potenti-
ation, while Romberg et al. (2009) found no change in average
PPR. As noted above, it may be that the initial release-probability
present at a particular connection affects the likelihood of pre-
synaptic plasticity at that synapse (see section The Effect of Initial
Release-Probability on the Locus of Plasticity).
Nitric oxide is also known to affect post-synaptic AMPA recep-
tor trafficking; NO increases GluA1 insertion acting via sGC
and protein kinase G (PKG) (Serulle et al., 2008) and GluA2
heteromer insertion by production of nitrosothiol groups on
NSF (N-ethylmaleimide-sensitive factor) (Huang et al., 2005).
Furthermore, endogenous NSF does appear to contain nitrosoth-
iol groups in vivo. (Huang et al., 2005). However, the GluA1
insertion mechanism cannot be the one operating in the GluA1
knockouts, leaving the GluA2 mechanism as the most likely to be
operating in these studies. This view is given further support by
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FIGURE 6 | Effects of NO on release-probability in cortical LTP. (A)
Intracellular application of the NOS antagonist L-NNA reduces but does not
abolish spike pairing LTP in wild-type mice. (B) Intracellular application of
L-NNA abolishes LTP in mice lacking the GluA1 subunit of the AMPA receptor.
(C) Examples of quantal analysis from a single release site input onto a layer
II/III neuron from a wild-type mouse; note that LTP occurs by an increase in
release-probability and quantal amplitude. (D) The plot of EPSP amplitude and
standard deviation for the example in (C) during the course of LTP (x = mean,
SD = standard deviation). (E) Example of quantal analysis from a double
release site case in a wild-type treated with intracellular L-NNA; note that LTP
occurs largely by an increase in quantal amplitude with a minor increase in
release-probability. Q is quantal amplitude, P is release-probability, and N is
the number of release sites. Adapted from Hardingham and Fox (2006) with
permission of the Society for Neuroscience.
data showing the PKC dependence of LTP in the GluA1 knock-
out animals (Romberg et al., 2009). Nevertheless, in wild-types it
is possible that both GluA1 and GluA2 are controlled by NO sig-
naling. Accumulation of cGMP in hippocampal cells has recently
been demonstrated using NO donors (Bartus et al., 2013) giving
further credence to a post-synaptic role for NO. Furthermore,
there is some evidence that dexras1 is activated by NO and is
located post-synaptically due to CAPON binding dexras1 and
NOS1 (Fang et al., 2000; Cheah et al., 2006). Together with
the substantial evidence that NO acts pre-synaptically (Section
NO Controls Pre-Synaptic Function), these findings raise the
intriguing possibility that NO might play a role in coordinat-
ing pre- and post-synaptic changes at excitatory synapses during
plasticity.
EVIDENCE FOR THE ROLE OF NO IN EXPERIENCE-DEPENDENT
PLASTICITY
There is an extensive literature on the role of NO in learning and
memory. Peripheral administration of NOS inhibitors have been
shown to impair spatial memory acquisition or recall (Bohme
et al., 1993; Chapman et al., 1992; Zou et al., 1998; Majlessi
et al., 2008), social interactions (Bohme et al., 1993) and object
recognition memory (Cobb et al., 1995). Central administra-
tion of NOS antagonists also alters behavior, including spatial
learning in the Morris water maze and the passive avoidance
test (Qiang et al., 1997; Majlessi et al., 2008; Li et al., 2012),
arguing against the peripheral effects of the drug. Inhibitors
more specific to NOS1 have also shown sensitivity to behav-
ioral performance in spatial reference and working memory
(Holscher et al., 1996; Zou et al., 1998; Yildiz Akar et al., 2009).
Furthermore, NOS1 knockout mice show impaired spatial mem-
ory, social interactions and contextual fear memory (Weitzdoerfer
et al., 2004; Kelley et al., 2009; Tanda et al., 2009). In con-
trast, NOS3 knockout mice exhibit enhanced spatial learning,
retention and reversal learning in the Morris water maze but
increased anxiety-like behaviors in the plus maze and the open
arena (Frisch et al., 2000). However, spatial learning is compa-
rable to controls in the radial arm maze (Dere et al., 2001),
suggesting that NOS3 knockout confers a specific deficit in spatial
learning and may therefore play a particular role in hippocam-
pal plasticity, where it has been shown to play a role in LTP in
concert with NOS1 (Hopper and Garthwaite, 2006; Phillips et al.,
2008).
A simpler form of experience-dependent plasticity that can be
quantified by measuring neuronal responses rather than behav-
ior is the plasticity that results from whisker deprivation in the
barrel cortex. Depriving a single whisker for several days leads
to expansion of the area of cortex dominated by that whisker
(Fox, 1992; Wallace and Fox, 1999). NO is implicated in the
potentiation component of this plasticity as αNOS1 knockouts
exhibited reduced single whisker potentiation (Dachtler et al.,
2011). In parallel with the LTP studies (Hardingham and Fox,
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FIGURE 7 | Effects of NO on the frequency of GABAergic spontaneous
IPSCs (sIPSCs). (A) Plot of the peak amplitudes of spontaneous IPSCs
against time for a thalamocortical (TC) lateral geniculate neuron. At the time
indicated by the gray panel a switch is made from voltage to current clamp
so that somatic action potentials can be generated. Note the increase in
sIPSCs on returning to voltage clamp and the block of all sIPSCs by
SR95531 toward the end of the experiment. (B) A similar recording from a
TC relay neuron with the same protocol as in (A), but in the presence of the
NO scavenger PTIO (20μM) in the external solution. Note that GABAergic
synaptic plasticity is blocked. Adapted from Bright and Brickley (2008) with
kind permission of the authors and the Physiological Society.
2006), experience-dependent potentiation was only abolished
in double knockouts of αNOS1 and GluA1 (Dachtler et al.,
2011). Plasticity was present in double knockouts of NOS3 and
GluA1, suggesting that αNOS1 is the important isoform in the
cortex, probably due to the close association between αNOS1
and the NMDA receptor (see section The Cellular Location of
NOS1). In further support of this idea, NMDA-dependent release
of NO is impaired in αNOS1 but not NOS3 knockout mice
(Dachtler et al., 2011).
Further analysis of plasticity in αNOS1 knockout mice reveals
both LTP and experience-dependent potentiation are abolished
in male but not female mice (Dachtler et al., 2012). This could
either mean that male mice rely solely on NO-dependent forms
of potentiation, or that some form of compensation for the lack
of NOS1 takes place in the female knockout mice that does not
occur in the males. The sex difference was not seen in wild-type
animals suggesting that the latter is a possible explanation. The
sex difference in the αNOS1 knockout mice may be of importance
to interpreting stroke data because factors involved in LTP are
often also involved in excitotoxicity. NOS1 has long been known
to be a factor in ischemic damage in stroke (Huang et al., 1994),
most likely through the association of αNOS1 and PSD-95 (Cao
et al., 2005). However, the magnitude of ischemic damage dif-
fers depending upon sex. Male αNOS1 knockout mice have less
ischemic damage than wild-types, while female αNOS1 knock-
out mice have more damage than their wild-type counterparts
(McCullough et al., 2005).
NO AND PLASTICITY AT GABAERGIC SYNAPSES
Because NO can play a role in pre-synaptic plasticity, it alsomeans
that it is not restricted to act on a particular set of post-synaptic
receptors or the protein trafficking machinery associated with
them. Instead, in so far as the vesicular release machinery is
common across transmitter systems, NO can potentially regulate
release for several different neurotransmitters including GABA
(Table 2).
Anatomical evidence implicates NO in regulation of pre-
synaptic GABA release. In excitatory pyramidal cells in the hip-
pocampus, NOS1 lies post synaptic to GABAergic synapses and
the “NO receptor” (sGC) lies in the pre-synaptic terminals of
those same GABAergic synapses, thereby providing both ele-
ments required for retrograde synaptic signaling in close assembly
(Szabadits et al., 2007). In this case, rather than being associated
with PSD95, which does not appear to localize at post-synaptic
densities of symmetric synapses, GRIP1 may bind NOS1 at the
post-synaptic site. The pre-synaptic terminals in question belong
to parvalbumin- and CCK-containing cells that synapse onto
somata and proximal dendrites of pyramidal cells. Consistent
with this location, application of NO donors increases cGMP
levels in GABAergic interneurons (Bartus et al., 2013). It is not
clear how the endogenous signal arises to activate NOS1 at these
inhibitory synapses, but one possibility is that action poten-
tials could raise intracellular calcium via voltage gated calcium
channels and the spatial localization of NOS1 immediately post-
synaptic to the GABAergic terminals targets NO to the inhibitory
terminals.
Physiological evidence further implicates NO in GABAergic
synaptic plasticity. Evidence comes from observations on par-
aventricular neurons (Li et al., 2002), the prepositus hypoglossal
nucleus (Moreno-Lopez et al., 2002), the amygdala (Lange et al.,
2012) and thalamic projection neurons (Bright and Brickley,
2008). In the hippocampus, NMDA receptor activation in pyra-
midal cells causes an increase in spontaneous GABAA receptor
mediated IPSCs that are sensitive to an NO scavenger (Xue et al.,
2011). In the ventral tegmental area, GABAergic synapses onto
dopaminergic neurons express a pre-synaptic form of LTP that is
dependent upon NMDA receptor activation, NO, GC, and PKG
for its induction and maintenance and is selective to GABAA
synapses (Nugent et al., 2007, 2009). Furthermore, pre-synaptic
GABAergic LTP from the lateral amygdala to the basolateral
amygdala depends upon NO generated from glutamatergic neu-
rons (Lange et al., 2012).
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Table 2 | The role of Nitric oxide in GABAergic function.
References Title Presynaptic
action?
Retrograde
messenger?
Effect? Structure
(preparation)
Lange et al., 2012 Heterosynaptic long-term potentiation
at interneuron-principal neuron
synapses in the amygdala requires
nitric oxide signaling
  Effect on plasticity Amygdala (slice)
Moreno-Lopez et al.,
2002
Nitric oxide facilitates GABAergic
neurotransmission in the cat
oculomotor system: a physiological
mechanism in eye movement control
  Controls velocity
responsiveness of
PH neurons
Medial vestibular
nucleus projection to
prepositus
hyperglossi (PH)
neurons (in vivo)
Szabadits et al., 2007 Hippocampal GABAergic synapses
possess the molecular machinery for
retrograde nitric oxide signaling
  Anatomical
evidence: nNOS is
post and sCG
presynaptic
Hippocampus
(in vivo)
Xue et al., 2011 NMDA receptor activation enhances
inhibitory GABAergic transmission
onto hippocampal pyramidal neurons
via presynaptic and postsynaptic
mechanisms
  Increase in sIPSP
frequency and
amplitude
Hippocampal (slice)
Yang et al., 2007 Kv1.1/1.2 channels are downstream
effectors of nitric oxide on synaptic
GABA release to preautonomic
neurons in the paraventricular nucleus
  Nitric oxide acts
on GABA via
Kv1.1/1.2
Paraventricular
nucleus of the
hypothalamus
(slices)
Yang et al., 2007 Kv1.1/1.2 channels are downstream
effectors of nitric oxide on synaptic
GABA release to preautonomic
neurons in the paraventricular nucleus
  Increases
frequency but not
amplitude of
inhibitory minis
Paraventricular
nucleus of the
hypothalamus
(slices)
Bright and Brickley, 2008 Acting locally but sensing globally:
impact of GABAergic synaptic
plasticity on phasic and tonic inhibition
in the thalamus
  Increases
frequency of
sIPSCs
Thalamus (slices)
Wall, 2003 Endogenous nitric oxide modulates
GABAergic transmission to granule
cells in adult rat cerebellum
  NO modulates
toninc GABA
release
Cerebellum (slices)
Holmgren and Zilberter,
2001
Coincident spiking activity induces
long-term changes in inhibition of
neocortical pyramidal cells
Analogous to
cases where nitric
oxide is involved
Neocortical (slices)
The studies on GABAergic potentiation in the thalamus are
particularly interesting because it only requires post-synaptic
action potentials, which cause an increase in spontaneous
GABAergic mIPSC frequency. This effect is blocked by the NO
scavenger PTIO (Bright and Brickley, 2008) suggesting that the
action potentials lead to release of NO that in turn produces
changes in GABA release (Figure 7). The NO donor SNAP can
also increase GABA mini frequency in these cells (Bright and
Brickley, 2008). The sufficiency of post-synaptic action poten-
tials in this study is reminiscent of the findings of Volgushev and
colleagues in the visual cortex, who showed that post-synaptic
action potentials produced NO-dependent potentiation in pyra-
midal cells (Volgushev et al., 2000) and Phillips et al. who
showed that NO-dependent LTP in the hippocampus relies on
somatic post-synaptic action potentials (Phillips et al., 2008).
These findings raise the possibility that post-synaptic action
potentials may simultaneously produce NO-dependent plastic-
ity at inhibitory synapses and spike timing-dependent plasticity
at excitatory synapses on the same cell, a property that may be
involved in maintenance of inhibitory-excitatory balance.
NO AND THE REGULATION OF EXCITATORY/INHIBITORY BALANCE
Cells in the cortex exhibit a balance between excitation and
inhibition such the ratio between inhibitory and excitatory con-
ductances is relatively constant for different inputs. For layer 5
pyramidal cells in the visual cortex, the ratio of excitatory to
inhibitory conductance has been estimated at 20:80 (Le Roux
et al., 2006) using the method of Monier et al. (2008). The
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excitatory/inhibitory (E/I) balance would be expected to be a uni-
versal phenomenon as loss of E/I balance in favor of excitation
leads to epilepsy. Consistent with this idea, inhibition has been
shown to be matched to excitation in the visual (Anderson et al.,
2000; Priebe and Ferster, 2005) auditory (Wehr and Zador, 2003,
2005) and somatosensory cortices (Wilent and Contreras, 2005).
Studies have shown that NO may play a role in the maintenance
of the E/I balance in the visual cortex. It can be demonstrated
that the E/I balance is maintained in layer 5 pyramidal cells
following potentiation by theta burst stimulation of cortical lay-
ers 2/3, 4 or 6 (Le Roux et al., 2006). Stimulating layer 4 and
increasing endogenous levels of NO by dosing a cortical slice with
L-arginine, or administration of an NO donor, also increases exci-
tatory and inhibitory conductances in balance (Le Roux et al.,
2009). These studies suggests that NO may play a homeostatic
role in maintaining the balance between excitation and inhibition
in the cortex.
CONCLUSIONS
Deciphering the role of NO in the brain has not been a simple
matter and at times the results of different studies have been con-
fusing. Nevertheless, a clearer picture is now emerging of how
NO might act to regulate synaptic function in the brain. In exci-
tatory cells, NOS1 is located discretely in spines and is tethered
to the post-synaptic membrane by its interaction with PSD95 in
complete contrast to its location in a subpopulation of NOS1+
NPY+ inhibitory cells, where NOS1 is located in the cytoplasm
along axons and dendrites and appears to be expressed at higher
levels. The low levels of NOS1 expression in excitatory cells of
the cortex and hippocampus dictate that under normal physio-
logical conditions low concentrations of NO are evolved during
stimulation by calcium, which in turn means that it has a rela-
tively small range and is therefore probably synapse-specific in its
action. The only obvious receptor that is sensitive at the low nM
to pM range is guanylate cyclase, although there is some evidence
for endogenous levels of proteins with nitrosothiol groups that
would require higher concentrations of NO. There is a substantial
body of literature that suggests that NO acts in a retrograde man-
ner on several aspects of vesicular release and recycling, so much
so that it would seem perverse to argue that NO does not act pre-
synaptically at this point. Present evidence suggests that NO acts
in a retrograde manner to affect not only glutamatergic synapses
but also GABAergic synapses as well as other transmitter systems.
Finally, there is substantial evidence in the literature that the ret-
rograde route of action is important for plasticity in the cortex
and hippocampus in both inhibitory and excitatory cells.
Nevertheless, a number of important questions remain about
the action of NO at synapses. Two questions relate to the concen-
tration of NO in the brain. First, are the levels of NO required for
nitrosothiol production at the SNARE complex proteins actually
achieved in vivo? Second, could higher levels of NO reported in
some studies be generated by the higher NOS levels present in the
NOS1+ GABAergic cells? A further set of questions relate to the
action of NO at pre-synaptic GABAergic synapses. There is evi-
dence that sGC is present in GABAergic terminals and that NOS1
lies post-synaptic to it (Szabadits et al., 2007). There is evidence
that GABAergic mini EPSC frequency increases following somatic
spiking in the LGn (Bright and Brickley, 2008). Therefore, what
is the mechanism of post-synaptic spike-dependent potentiation
of GABAergic transmission and is it indeed NO-dependent in
the cortex and hippocampus? More generally, is this mechanism
related to the post-synaptic spike potentiation present at exci-
tatory synapses (Volgushev et al., 2000)? Unraveling this effect
could help us understand whether the E/I balance is maintained
by NO acting simultaneously on GABAergic and excitatory trans-
mission (Le Roux et al., 2009). Finally, while we have concentrated
on the pre-synaptic role of NO in this review, there is evidence
that NO also has a post-synaptic action. In addition to activation
of post-synaptic sGC, there is evidence that post-synaptic pro-
teins have nitrosothiol groups, particularly those close to its PSD
location (see Figure 1). If NO also has a post-synaptic role in plas-
ticity it raises the additional question about whether it can play a
homeostatic role in balancing or matching pre- and post-synaptic
function. With a little good fortune, it will not take another 25
years of research to solve these and other related questions on the
role NO plays in synaptic function in the brain.
ACKNOWLEDGMENTS
We should like to acknowledge the support of the MRC to Kevin
Fox for the authors’ own work. We should also like to thank
John Garthwaite for critically reading an earlier draft of the
manuscript.
REFERENCES
Aarts, M., Liu, Y., Liu, L., Besshoh,
S., Arundine, M., Gurd, J. W.,
et al. (2002). Treatment of ischemic
brain damage by perturbing NMDA
receptor- PSD-95 protein interac-
tions. Science 298, 846–850. doi:
10.1126/science.1072873
Ahern, G. P., Klyachko, V. A., and
Jackson, M. B. (2002). cGMP and
S-nitrosylation: two routes for
modulation of neuronal excitabil-
ity by NO. Trends Neurosci. 25,
510–517. doi: 10.1016/S0166-
2236(02)02254-3
Anderson, J. S., Carandini, M., and
Ferster, D. (2000). Orientation
tuning of input conductance,
excitation, and inhibition in cat pri-
mary visual cortex. J. Neurophysiol.
84, 909–926.
Antonova, I., Arancio, O., Trillat, A. C.,
Wang, H. G., Zablow, L., Udo, H.,
et al. (2001). Rapid increase in clus-
ters of presynaptic proteins at onset
of long-lasting potentiation. Science
294, 1547–1550. doi: 10.1126/sci-
ence.1066273
Aoki, C., Bredt, D. S., Fenstemaker,
S., and Lubin, M. (1998). The
subcellular distribution of nitric
oxide synthase relative to the NR1
subunit of NMDA receptors in the
cerebral cortex. Prog. Brain Res.
118, 83–97. doi: 10.1016/S0079-
6123(08)63202-1
Aoki, C., Rhee, J., Lubin, M., and
Dawson, T. M. (1997). NMDA-
R1 subunit of the cerebral cor-
tex co-localizes with neuronal nitric
oxide synthase at pre- and post-
synaptic sites and in spines. Brain
Res. 750, 25–40. doi: 10.1016/S0006-
8993(96)01147-X
Arancio, O., Antonova, I., Gambaryan,
S., Lohmann, S. M., Wood,
J. S., Lawrence, D. S., et al.
(2001). Presynaptic role of
cGMP-dependent protein kinase
during long-lasting potentiation.
J. Neurosci. 21, 143–149.
Arancio, O., Kandel, E. R., and
Hawkins, R. D. (1995). Activity-
dependent long-term enhancement
of transmitter release by presynap-
tic 3′,5′-cyclic GMP in cultured
hippocampal neurons. Nature 376,
74–80. doi: 10.1038/376074a0
Arancio, O., Kiebler, M., Lee, C. J., Lev-
Ram, V., Tsien, R. Y., Kandel, E.
R., et al. (1996a). Nitric oxide acts
directly in the presynaptic neuron to
produce long-term potentiation in
cultured hippocampal neurons. Cell
87, 1025–1035. doi: 10.1016/S0092-
8674(00)81797-3
Arancio, O., Lev-Ram, V., Tsien, R. Y.,
Kandel, E. R., and Hawkins, R. D.
(1996b). Nitric oxide acts as a
retrograde messenger during long-
term potentiation in cultured hip-
pocampal neurons. J. Physiol. Paris
Frontiers in Cellular Neuroscience www.frontiersin.org October 2013 | Volume 7 | Article 190 | 14
Hardingham et al. Nitric oxide and pre-synaptic plasticity
90, 321–322. doi: 10.1016/S0928-
4257(97)87907-7
Bartus, K., Pigott, B., and Garthwaite,
J. (2013). Cellular targets of nitric
oxide in the hippocampus. PLoS
ONE 8:e57292. doi: 10.1371/jour-
nal.pone.0057292
Batchelor, A.M., Bartus, K., Reynell, C.,
Constantinou, S., Halvey, E. J., Held,
K. F., et al. (2010). Exquisite sensi-
tivity to subsecond, picomolar nitric
oxide transients conferred on cells
by guanylyl cyclase-coupled recep-
tors. Proc. Natl. Acad. Sci. U.S.A.
107, 22060–22065. doi: 10.1073/
pnas.1013147107
Bellamy, T. C., and Garthwaite, J.
(2001). Sub-second kinetics of
the nitric oxide receptor, soluble
guanylyl cyclase, in intact cere-
bellar cells. J. Biol. Chem. 276,
4287–4292. doi: 10.1074/jbc.
M006677200
Blackshaw, S., Eliasson, M. J., Sawa, A.,
Watkins, C. C., Krug, D., Gupta,
A., et al. (2003). Species, strain and
developmental variations in hip-
pocampal neuronal and endothelial
nitric oxide synthase clarify discrep-
ancies in nitric oxide-dependent
synaptic plasticity. Neuroscience
119, 979–990. doi: 10.1016/S0306-
4522(03)00217-3
Bohme, G. A., Bon, C., Lemaire, M.,
Reibaud, M., Piot, O., Stutzmann,
J. M., et al. (1993). Altered synap-
tic plasticity and memory for-
mation in nitric oxide synthase
inhibitor-treated rats. Proc. Natl.
Acad. Sci. U.S.A. 90, 9191–9194. doi:
10.1073/pnas.90.19.9191
Bohme, G. A., Bon, C., Stutzmann,
J. M., Doble, A., and Blanchard,
J. C. (1991). Possible involvement
of nitric oxide in long-term poten-
tiation. Eur. J. Pharmacol. 199,
379–381. doi: 10.1016/0014-2999
(91)90505-K
Brenman, J. E., and Bredt, D. S.
(1997). Synaptic signaling by nitric
oxide. Curr. Opin. Neurobiol. 7,
374–378. doi: 10.1016/S0959-4388
(97)80065-7
Brenman, J. E., Chao, D. S., Gee,
S. H., Mcgee, A. W., Craven, S.
E., Santillano, D. R., et al. (1996).
Interaction of nitric oxide synthase
with the postsynaptic density pro-
tein PSD-95 and alpha1-syntrophin
mediated by PDZ domains. Cell
84, 757–767. doi: 10.1016/S0092-
8674(00)81053-3
Bright, D. P., and Brickley, S. G. (2008).
Acting locally but sensing globally:
impact of GABAergic synaptic plas-
ticity on phasic and tonic inhibi-
tion in the thalamus. J. Physiol.
586, 5091–5099. doi: 10.1113/jphys-
iol.2008.158576
Broillet, M. C., and Firestein, S. (1997).
Beta subunits of the olfactory cyclic
nucleotide-gated channel form a
nitric oxide activated Ca2+ channel.
Neuron 18, 951–958. doi: 10.1016/
S0896-6273(00)80334-7
Buchwalow, I. B., Podzuweit, T., Bocker,
W., Samoilova, V. E., Thomas, S.,
Wellner, M., et al. (2002). Vascular
smoothmuscle and nitric oxide syn-
thase. FASEB J. 16, 500–508. doi:
10.1096/fj.01-0842com
Burette, A., Zabel, U., Weinberg, R. J.,
Schmidt, H. H., and Valtschanoff,
J. G. (2002). Synaptic localiza-
tion of nitric oxide synthase and
soluble guanylyl cyclase in the
hippocampus. J. Neurosci. 22,
8961–8970.
Buskila, Y., and Amitai, Y. (2010).
Astrocytic iNOS-dependent
enhancement of synaptic release in
mouse neocortex. J. Neurophysiol.
103, 1322–1328. doi: 10.1152/jn.
00676.2009
Calabrese, V., Mancuso, C., Calvani,
M., Rizzarelli, E., Butterfield, D. A.,
and Stella, A. M. (2007). Nitric
oxide in the central nervous system:
neuroprotection versus neurotoxic-
ity. Nat. Rev. Neurosci. 8, 766–775.
doi: 10.1038/nrn2214
Cao, J., Viholainen, J. I., Dart, C.,
Warwick, H. K., Leyland, M.
L., and Courtney, M. J. (2005).
The PSD95-nNOS interface: a
target for inhibition of excito-
toxic p38 stress-activated protein
kinase activation and cell death.
J. Cell Biol. 168, 117–126. doi:
10.1083/jcb.200407024
Chapman, P. F., Atkins, C. M., Allen,
M. T., Haley, J. E., and Steinmetz,
J. E. (1992). Inhibition of nitric
oxide synthesis impairs two differ-
ent forms of learning. Neuroreport
3, 567–570. doi: 10.1097/00001756-
199207000-00005
Cheah, J. H., Kim, S. F., Hester, L.
D., Clancy, K. W., Patterson, S.
E. 3rd., Papadopoulos, V., et al.
(2006). NMDA receptor-nitric
oxide transmission mediates
neuronal iron homeostasis via
the GTPase Dexras1. Neuron 51,
431–440. doi: 10.1016/j.neuron.
2006.07.011
Cobb, B. L., Ryan, K. L., Frei, M.
R., Guel-Gomez, V., and Mickley,
G. A. (1995). Chronic adminis-
tration of L-NAME in drinking
water alters working mem-
ory in rats. Brain Res. Bull. 38,
203–207. doi: 10.1016/0361-9230
(95)00095-V
Contestabile, A. (2000). Roles of
NMDA receptor activity and
nitric oxide production in
brain development. Brain Res.
Brain Res. Rev. 32, 476–509. doi:
10.1016/S0165-0173(00)00018-7
Corsani, L., Bizzoco, E., Pedata,
F., Gianfriddo, M., Faussone-
Pellegrini, M. S., and Vannucchi,
M. G. (2008). Inducible nitric
oxide synthase appears and is
co-expressed with the neuronal
isoform in interneurons of the
rat hippocampus after transient
ischemia induced by middle cere-
bral artery occlusion. Exp. Neurol.
211, 433–440. doi: 10.1016/j.
expneurol.2008.02.008
Dachtler, J., Hardingham, N. R.,
and Fox, K. (2012). The role
of nitric oxide synthase in cor-
tical plasticity is sex specific.
J. Neurosci. 32, 14994–14999.
doi: 10.1523/JNEUROSCI.3189-
12.2012
Dachtler, J., Hardingham, N. R.,
Glazewski, S., Wright, N. F.,
Blain, E. J., and Fox, K. (2011).
Experience-dependent plastic-
ity acts via GluR1 and a novel
neuronal nitric oxide synthase-
dependent synaptic mechanism
in adult cortex. J. Neurosci. 31,
11220–11230. doi: 10.1523/
JNEUROSCI.1590-11.2011
Dere, E., Frisch, C., De Souza Silva,
M. A., Godecke, A., Schrader, J.,
and Huston, J. P. (2001). Unaltered
radial maze performance and brain
acetylcholine of the endothelial
nitric oxide synthase knock-
out mouse. Neuroscience 107,
561–570. doi: 10.1016/S0306-4522
(01)00382-7
Di Stasi, A. M., Mallozzi, C., Macchia,
G., Maura, G., Petrucci, T. C., and
Minetti, M. (2002). Peroxynitrite
affects exocytosis and SNARE
complex formation and induces
tyrosine nitration of synap-
tic proteins. J. Neurochem. 82,
420–429. doi: 10.1046/j.1471-4159.
2002.00980.x
Dinerman, J. L., Dawson, T. M.,
Schell, M. J., Snowman, A., and
Snyder, S. H. (1994). Endothelial
nitric oxide synthase localized
to hippocampal pyramidal cells:
implications for synaptic plasticity.
Proc. Natl. Acad. Sci. U.S.A. 91,
4214–4218. doi: 10.1073/pnas.91.
10.4214
Doucet, M. V., Harkin, A., and
Dev, K. K. (2012). The PSD-
95/nNOS complex: new drugs for
depression? Pharmacol. Ther. 133,
218–229. doi: 10.1016/j.
pharmthera.2011.11.005
Doyle, C., Holscher, C., Rowan, M.
J., and Anwyl, R. (1996). The
selective neuronal NO synthase
inhibitor 7-nitro-indazole blocks
both long-term potentiation and
depotentiation of field EPSPs in
rat hippocampal CA1 in vivo.
J. Neurosci. 16, 418–424.
Eguchi, K., Nakanishi, S., Takagi,
H., Taoufiq, Z., and Takahashi,
T. (2012). Maturation of a PKG-
dependent retrograde mechanism
for exoendocytic coupling of
synaptic vesicles. Neuron 74,
517–529. doi: 10.1016/j.neuron.
2012.03.028
Eliasson, M. J., Blackshaw, S., Schell,
M. J., and Snyder, S. H. (1997).
Neuronal nitric oxide synthase
alternatively spliced forms: promi-
nent functional localizations
in the brain. Proc. Natl Acad.
Sci. U.S.A. 94, 3396–3401. doi:
10.1073/pnas.94.7.3396
Fang, M., Jaffrey, S. R., Sawa, A., Ye,
K., Luo, X., and Snyder, S. H.
(2000). Dexras1: a G protein specif-
ically coupled to neuronal nitric
oxide synthase via CAPON. Neuron
28, 183–193. doi: 10.1016/S0896-
6273(00)00095-7
Feil, R., and Kleppisch, T. (2008).
NO/cGMP-dependent modula-
tion of synaptic transmission.
Handb. Exp. Pharmacol. 184,
529–560. doi: 10.1007/978-3-540-
74805-2_16
Florio, S. K., Loh, C., Huang, S.
M., Iwamaye, A. E., Kitto, K.
F., Fowler, K. W., et al. (2009).
Disruption of nNOS-PSD95
protein-protein interaction inhibits
acute thermal hyperalgesia and
chronic mechanical allodynia in
rodents. Br. J. Pharmacol. 158,
494–506. doi: 10.1111/j.1476-5381.
2009.00300.x
Fox, K. (1992). A critical period for
experience-dependent synaptic
plasticity in rat barrel cortex.
J. Neurosci. 12, 1826–1838.
Friebe, A., and Koesling, D. (2009).
The function of NO-sensitive
guanylyl cyclase: what we can
learn from genetic mouse models.
Nitric Oxide 21, 149–156. doi:
10.1016/j.niox.2009.07.004
Frisch, C., Dere, E., Silva, M. A.,
Godecke, A., Schrader, J., and
Huston, J. P. (2000). Superior
water maze performance and
increase in fear-related behavior
in the endothelial nitric oxide
synthase-deficient mouse together
with monoamine changes in
cerebellum and ventral striatum.
J. Neurosci. 20, 6694–6700.
Garthwaite, J. (2008). Concepts of
neural nitric oxide-mediated
transmission. Eur. J. Neurosci. 27,
2783–2802. doi: 10.1111/j.1460-
9568.2008.06285.x
Garthwaite, J. (2010). New insight
into the functioning of nitric
Frontiers in Cellular Neuroscience www.frontiersin.org October 2013 | Volume 7 | Article 190 | 15
Hardingham et al. Nitric oxide and pre-synaptic plasticity
oxide-receptive guanylyl cyclase:
physiological and pharmacological
implications. Mol. Cell Biochem.
334, 221–232. doi: 10.1007/s11010-
009-0318-8
Garthwaite, J., Charles, S. L., and
Chess-Williams, R. (1988).
Endothelium-derived relaxing
factor release on activation of
NMDA receptors suggests role as
intercellular messenger in the brain.
Nature 336, 385–388. doi: 10.1038/
336385a0
Gibb, B. J., and Garthwaite, J. (2001).
Subunits of the nitric oxide receptor,
soluble guanylyl cyclase, expressed
in rat brain. Eur. J. Neurosci. 13,
539–544. doi: 10.1046/j.1460-9568.
2001.01421.x
Gordon, G. R., Mulligan, S. J., and
Macvicar, B. A. (2007). Astrocyte
control of the cerebrovasculature.
Glia 55, 1214–1221. doi: 10.1002/
glia.20543
Griffiths, C., Wykes, V., Bellamy, T.
C., and Garthwaite, J. (2003).
A new and simple method for
delivering clamped nitric oxide
concentrations in the physiological
range: application to activation
of guanylyl cyclase-coupled nitric
oxide receptors.Mol. Pharmacol. 64,
1349–1356. doi: 10.1124/mol.64.6.
1349
Haghikia, A., Mergia, E., Friebe, A.,
Eysel, U. T., Koesling, D., and
Mittmann, T. (2007). Long-term
potentiation in the visual cortex
requires both nitric oxide receptor
guanylyl cyclases. J. Neurosci.
27, 818–823. doi: 10.1523/
JNEUROSCI.4706-06.2007
Haley, J. E., Malen, P. L., and Chapman,
P. F. (1993). Nitric oxide syn-
thase inhibitors block long-term
potentiation induced by weak but
not strong tetanic stimulation at
physiological brain temperatures in
rat hippocampal slices. Neurosci.
Lett. 160, 85–88. doi: 10.1016/0304-
3940(93)90919-C
Hall, C. N., and Garthwaite, J. (2009).
What is the real physiological NO
concentration in vivo? Nitric Oxide
21, 92–103. doi: 10.1016/j.niox.
2009.07.002
Hardingham, N., and Fox, K. (2006).
The role of nitric oxide and GluR1
in presynaptic and postsynaptic
components of neocortical poten-
tiation. J. Neurosci. 26, 7395–7404.
doi: 10.1523/JNEUROSCI.0652-06.
2006
Hardingham, N. R., Hardingham,
G. E., Fox, K. D., and Jack, J.
J. (2007). Presynaptic efficacy
directs normalization of synap-
tic strength in layer 2/3 rat
neocortex after paired activity.
J. Neurophysiol. 97, 2965–2975. doi:
10.1152/jn.01352.2006
Heinrich, T. A., Da Silva, R. S.,
Miranda, K. M., Switzer, C. H.,
Wink, D. A., and Fukuto, J. M.
(2013). Biological nitric oxide sig-
nalling: chemistry and terminology.
Br. J. Pharmacol. 169, 1417–1429.
doi: 10.1111/bph.12217
Hickey, M. J. (2001). Role of inducible
nitric oxide synthase in the
regulation of leucocyte recruit-
ment. Clin. Sci. (Lond.) 100, 1–12.
doi: 10.1042/CS20000135
Holmgren, C. D., and Zilberter, Y.
(2001). Coincident spiking activ-
ity induces long-term changes
in inhibition of neocortical
pyramidal cells. J. Neurosci. 21,
8270–8277.
Holscher, C. (1997). Nitric oxide,
the enigmatic neuronal mes-
senger: its role in synaptic
plasticity. Trends Neurosci. 20,
298–303. doi: 10.1016/S0166-2236
(97)01065-5
Holscher, C., Mcglinchey, L., Anwyl,
R., and Rowan, M. J. (1996). 7-
Nitro indazole, a selective neu-
ronal nitric oxide synthase inhibitor
in vivo, impairs spatial learning in
the rat. Learn.Mem. 2, 267–278. doi:
10.1101/lm.2.6.267
Hopper, R. A., and Garthwaite, J.
(2006). Tonic and phasic nitric
oxide signals in hippocampal long-
term potentiation. J. Neurosci. 26,
11513–11521. doi: 10.1523/
JNEUROSCI.2259-06.2006
Huang, C. C., Chan, S. H., and Hsu,
K. S. (2003). cGMP/protein kinase
G-dependent potentiation of glu-
tamatergic transmission induced
by nitric oxide in immature rat
rostral ventrolateral medulla neu-
rons in vitro. Mol. Pharmacol. 64,
521–532. doi: 10.1124/mol.64.
2.521
Huang, P. L., Dawson, T. M., Bredt, D.
S., Snyder, S. H., and Fishman,M. C.
(1993). Targeted disruption of the
neuronal nitric oxide synthase gene.
Cell 75, 1273–1286. doi: 10.1016/
0092-8674(93)90615-W
Huang, Y., Man, H. Y., Sekine-Aizawa,
Y., Han, Y., Juluri, K., Luo, H.,
et al. (2005). S-nitrosylation of
N-ethylmaleimide sensitive fac-
tor mediates surface expression
of AMPA receptors. Neuron 46,
533–540. doi: 10.1016/j.neuron.
2005.03.028
Huang, Z., Huang, P. L., Panahian, N.,
Dalkara, T., Fishman, M. C., and
Moskowitz, M. A. (1994). Effects
of cerebral ischemia in mice defi-
cient in neuronal nitric oxide syn-
thase. Science 265, 1883–1885. doi:
10.1126/science.7522345
Husi, H., Ward, M. A., Choudhary, J.
S., Blackstock, W. P., and Grant,
S. G. (2000). Proteomic analy-
sis of NMDA receptor-adhesion
protein signaling complexes. Nat.
Neurosci. 3, 661–669. doi: 10.1038/
76615
Jaffrey, S. R., Erdjument-Bromage,
H., Ferris, C. D., Tempst, P., and
Snyder, S. H. (2001). Protein
S-nitrosylation: a physiological
signal for neuronal nitric oxide.
Nat. Cell Biol. 3, 193–197. doi:
10.1038/35055104
Jaffrey, S. R., Snowman, A.M., Eliasson,
M. J., Cohen, N. A., and Snyder,
S. H. (1998). CAPON: a pro-
tein associated with neuronal nitric
oxide synthase that regulates its
interactions with PSD95. Neuron
20, 115–124. doi: 10.1016/S0896-
6273(00)80439-0
Johnstone, V. P., and Raymond, C.
R. (2011). A protein synthesis and
nitric oxide-dependent presynaptic
enhancement in persistent forms
of long-term potentiation. Learn
Mem. 18, 625–633. doi: 10.1101/lm.
2245911
Kaneko, M., Cheetham, C. E., Lee, Y.
S., Silva, A. J., Stryker, M. P., and
Fox, K. (2010). Constitutively active
H-ras accelerates multiple forms of
plasticity in developing visual cor-
tex. Proc. Natl. Acad. Sci. U.S.A. 107,
19026–19031. doi: 10.1073/pnas.
1013866107
Kawaguchi, Y., Aosaki, T., and
Kubota, Y. (1997). Cholinergic
and GABAergic interneurons
in the striatum. Nihon Shinkei
Seishin Yakurigaku Zasshi 17,
87–90.
Kelley, J. B., Balda, M. A., Anderson,
K. L., and Itzhak, Y. (2009).
Impairments in fear conditioning
in mice lacking the nNOS gene.
Learn. Mem. 16, 371–378. doi:
10.1101/lm.1329209
Kerr, M. I., Wall, M. J., and Richardson,
M. J. (2013). Adenosine A1-
receptor activation mediates the
developmental shift at layer-5
pyramidal-cell synapses and is a
determinant of mature synap-
tic strength. J. Physiol. 591,
3371–3380. doi: 10.1113/jphysiol.
2012.244392
Kimura, S., Uchiyama, S., Takahashi, H.
E., and Shibuki, K. (1998). cAMP-
dependent long-term potentiation
of nitric oxide release from cerebel-
lar parallel fibers in rats. J. Neurosci.
18, 8551–8558.
Kingston, P. A., Zufall, F., and
Barnstable, C. J. (1999). Widespread
expression of olfactory cyclic
nucleotide-gated channel genes in
rat brain: implications for neuronal
signalling. Synapse 32, 1–12. doi:
10.1002/(SICI)1098-2396(199904)
32:1<1::AID-SYNI>3.0.CO;2-M
Klyachko, V. A., Ahern, G. P., and
Jackson, M. B. (2001). cGMP-
mediated facilitation in nerve
terminals by enhancement of
the spike afterhyperpolariza-
tion. Neuron 31, 1015–1025. doi:
10.1016/S0896-627300449-4
Kodama, T., and Koyama, Y. (2006).
Nitric oxide from the laterodorsal
tegmental neurons: its possible
retrograde modulation on nore-
pinephrine release from the axon
terminal of the locus coeruleus neu-
rons. Neuroscience 138, 245–256.
doi: 10.1016/j.neuroscience.2005.
10.063
Kubota, Y., Shigematsu, N., Karube, F.,
Sekigawa, A., Kato, S., Yamaguchi,
N., et al. (2011). Selective coexpres-
sion of multiple chemical markers
defines discrete populations of
neocortical GABAergic neurons.
Cereb. Cortex 21, 1803–1817. doi:
10.1093/cercor/bhq252
Lange, M. D., Doengi, M., Lesting,
J., Pape, H. C., and Jungling, K.
(2012). Heterosynaptic long-term
potentiation at interneuron-
principal neuron synapses in
the amygdala requires nitric
oxide signalling. J. Physiol. 590,
131–143. doi: 10.1113/jphysiol.
2011.221317
Larkman, A., Hannay, T., Stratford,
K., and Jack, J. (1992). Presynaptic
release probability influences
the locus of long-term potenti-
ation. Nature 360, 70–73. doi:
10.1038/360070a0
Le Roux, N., Amar, M., Baux, G.,
and Fossier, P. (2006). Homeostatic
control of the excitation-inhibition
balance in cortical layer 5 pyra-
midal neurons. Eur. J. Neurosci.
24, 3507–3518. doi: 10.1111/j.1460-
9568.2006.05203.x
Le Roux, N., Amar, M., Moreau, A.
W., and Fossier, P. (2009). Roles
of nitric oxide in the homeostatic
control of the excitation-inhibition
balance in rat visual cortical
networks. Neuroscience 163,
942–951. doi: 10.1016/j.
neuroscience.2009.07.010
Leinders-Zufall, T., Cockerham,
R. E., Michalakis, S., Biel, M.,
Garbers, D. L., Reed, R. R.,
et al. (2007). Contribution of
the receptor guanylyl cyclase
GC-D to chemosensory func-
tion in the olfactory epithelium.
Proc. Natl. Acad. Sci. U.S.A. 104,
14507–14512. doi: 10.1073/pnas.
0704965104
Li, C. H., Wang, S. Z., Cai, Z. L.,
Liu, W. X., Xu, S. T., and Xiao, P.
Frontiers in Cellular Neuroscience www.frontiersin.org October 2013 | Volume 7 | Article 190 | 16
Hardingham et al. Nitric oxide and pre-synaptic plasticity
(2012). Effects of intrahippocam-
pal L-NAME treatment on the
behavioral long-term potentiation
in dentate gyrus. Neurosci. Lett. 528,
201–204. doi: 10.1016/j.neulet.2012.
08.056
Li, D. P., Chen, S. R., and Pan, H. L.
(2002). Nitric oxide inhibits spinally
projecting paraventricular neurons
through potentiation of presynaptic
GABA release. J. Neurophysiol. 88,
2664–2674. doi: 10.1152/jn.00540.
2002
Lindskog, M., Li, L., Groth, R. D.,
Poburko, D., Thiagarajan, T. C.,
Han, X., et al. (2010). Postsynaptic
GluA1 enables acute retrograde
enhancement of presynaptic
function to coordinate adap-
tation to synaptic inactivity.
Proc. Natl. Acad. Sci. U.S.A. 107,
21806–21811. doi: 10.1073/pnas.
1016399107
Majlessi, N., Choopani, S.,
Bozorgmehr, T., and Azizi, Z.
(2008). Involvement of hip-
pocampal nitric oxide in spatial
learning in the rat. Neurobiol.
Learn. Mem. 90, 413–419. doi:
10.1016/j.nlm.2008.04.010
Malen, P. L., and Chapman, P. F.
(1997). Nitric oxide facilitates long-
term potentiation, but not long-
term depression. J. Neurosci. 17,
2645–2651.
Malinow, R., and Tsien, R. W. (1990).
Presynaptic enhancement shown
by whole-cell recordings of long-
term potentiation in hippocampal
slices. Nature 346, 177–180. doi:
10.1038/346177a0
Martin, E., Berka, V., Bogatenkova,
E., Murad, F., and Tsai, A. L.
(2006). Ligand selectivity of sol-
uble guanylyl cyclase: effect of
the hydrogen-bonding tyrosine
in the distal heme pocket on
binding of oxygen, nitric oxide,
and carbon monoxide. J. Biol.
Chem. 281, 27836–27845. doi:
10.1074/jbc.M601078200
McCullough, L. D., Zeng, Z., Blizzard,
K. K., Debchoudhury, I., and
Hurn, P. D. (2005). Ischemic nitric
oxide and poly (ADP-ribose)
polymerase-1 in cerebral ischemia:
male toxicity, female protection.
J. Cereb. Blood Flow Metab. 25,
502–512. doi: 10.1038/sj.jcbfm.
9600059
Meffert, M. K., Calakos, N. C.,
Scheller, R. H., and Schulman,
H. (1996). Nitric oxide mod-
ulates synaptic vesicle docking
fusion reactions. Neuron 16,
1229–1236. doi: 10.1016/S0896-
6273(00)80149-X
Meffert, M. K., Premack, B. A., and
Schulman, H. (1994). Nitric oxide
stimulates Ca(2+)-independent
synaptic vesicle release. Neuron 12,
1235–1244. doi: 10.1016/0896-6273
(94)90440-5
Mergia, E., Russwurm, M., Zoidl, G.,
and Koesling, D. (2003). Major
occurrence of the new alpha2beta1
isoform of NO-sensitive guany-
lyl cyclase in brain. Cell Signal.
15, 189–195. doi: 10.1016/S0898-
6568(02)00078-5
Micheva, K. D., Buchanan, J., Holz,
R. W., and Smith, S. J. (2003).
Retrograde regulation of synap-
tic vesicle endocytosis and recy-
cling.Nat. Neurosci. 6, 925–932. doi:
10.1038/nn1114
Monier, C., Fournier, J., and Fregnac, Y.
(2008). In vitro and in vivomeasures
of evoked excitatory and inhibitory
conductance dynamics in sensory
cortices. J. Neurosci. Methods 169,
323–365. doi: 10.1016/j.jneumeth.
2007.11.008
Montague, P. R., Gancayco, C.
D., Winn, M. J., Marchase,
R. B., and Friedlander, M. J.
(1994). Role of NO production
in NMDA receptor-mediated
neurotransmitter release in cerebral
cortex. Science 263, 973–977. doi:
10.1126/science.7508638
Moreno-Lopez, B., Escudero, M., and
Estrada, C. (2002). Nitric oxide
facilitates GABAergic neurotrans-
mission in the cat oculomotor sys-
tem: a physiological mechanism in
eye movement control. J. Physiol.
540, 295–306. doi: 10.1113/jphys-
iol.2001.013308
Neitz, A., Mergia, E., Eysel, U. T.,
Koesling, D., and Mittmann,
T. (2011). Presynaptic nitric
oxide/cGMP facilitates glutamate
release via hyperpolarization-
activated cyclic nucleotide-gated
channels in the hippocam-
pus. Eur. J. Neurosci. 33,
1611–1621. doi: 10.1111/j.1460-
9568.2011.07654.x
Nikonenko, I., Boda, B., Steen, S.,
Knott, G., Welker, E., and Muller,
D. (2008). PSD-95 promotes synap-
togenesis and multiinnervated
spine formation through nitric
oxide signaling. J. Cell Biol. 183,
1115–1127. doi: 10.1083/jcb.2008
05132
Nomura, Y., and Kitamura, Y. (1993).
Inducible nitric oxide synthase
in glial cells. Neurosci Res 18,
103–107. doi: 10.1016/0168-0102
(93)90013-G
Nugent, F. S., Niehaus, J. L., and
Kauer, J. A. (2009). PKG and PKA
signaling in LTP at GABAergic
synapses. Neuropsychopharmacology
34, 1829–1842. doi: 10.1038/
npp.2009.5
Nugent, F. S., Penick, E. C., and
Kauer, J. A. (2007). Opioids
block long-term potentiation
of inhibitory synapses. Nature
446, 1086–1090. doi: 10.1038/
nature05726
O’Dell, T. J., Hawkins, R. D., Kandel,
E. R., and Arancio, O. (1991). Tests
of the roles of two diffusible sub-
stances in long-term potentiation:
evidence for nitric oxide as a pos-
sible early retrograde messenger.
Proc. Natl. Acad. Sci. U.S.A. 88,
11285–11289. doi: 10.1073/pnas.88.
24.11285
Ondracek, J. M., Dec, A., Hoque,
K. E., Lim, S. A., Rasouli, G.,
Indorkar, R. P., et al. (2008).
Feed-forward excitation of striatal
neuron activity by frontal cortical
activation of nitric oxide signal-
ing in vivo. Eur. J. Neurosci. 27,
1739–1754. doi: 10.1111/j.1460-
9568.2008.06157.x
Palmer, Z. J., Duncan, R. R., Johnson,
J. R., Lian, L. Y., Mello, L. V., Booth,
D., et al. (2008). S-nitrosylation
of syntaxin 1 at Cys(145) is a
regulatory switch controlling
Munc18-1 binding. Biochem. J. 413,
479–491. doi: 10.1042/BJ20080069
Parent, A., Schrader, K., Munger, S.
D., Reed, R. R., Linden, D. J., and
Ronnett, G. V. (1998). Synaptic
transmission and hippocampal
long-term potentiation in olfactory
cyclic nucleotide-gated channel
type 1 null mouse. J. Neurophysiol.
79, 3295–3301.
Phillips, K. G., Hardingham, N. R., and
Fox, K. (2008). Postsynaptic action
potentials are required for nitric-
oxide-dependent long-term poten-
tiation in CA1 neurons of adult
GluR1 knock-out and wild-type
mice. J. Neurosci. 28, 14031–14041.
doi: 10.1523/JNEUROSCI.3984-08.
2008
Poglia, L., Muller, D., and Nikonenko,
I. (2011). Ultrastructural
modifications of spine and
synapse morphology by SAP97.
Hippocampus 21, 990–998. doi:
10.1002/hipo.20811
Priebe, N. J., and Ferster, D.
(2005). Direction selectivity
of excitation and inhibition
in simple cells of the cat pri-
mary visual cortex. Neuron 45,
133–145. doi: 10.1016/j.neuron.
2004.12.024
Prince, D. A., and Stevens, C. F.
(1992). Adenosine decreases
neurotransmitter release at cen-
tral synapses. Proc. Natl. Acad.
Sci. U.S.A. 89, 8586–8590. doi:
10.1073/pnas.89.18.8586
Prior, I. A., and Clague, M. J. (2000).
Detection of thiol modification
following generation of reac-
tive nitrogen species: analysis
of synaptic vesicle proteins.
Biochim. Biophys. Acta 1475,
281–286. doi: 10.1016/S0304-4165
(00)00078-7
Qiang, M., Chen, Y. C., Wang, R.,
Wu, F. M., and Qiao, J. T. (1997).
Nitric oxide is involved in the for-
mation of learning and memory in
rats: studies using passive avoid-
ance response and Morris water
maze task. Behav. Pharmacol. 8,
183–187.
Qiu, D. L., and Knopfel, T. (2007).
An NMDA receptor/nitric oxide
cascade in presynaptic parallel
fiber-Purkinje neuron long-term
potentiation. J. Neurosci. 27,
3408–3415. doi: 10.1523/
JNEUROSCI.4831-06.2007
Ratnayaka, A., Marra, V., Bush, D.,
Burden, J. J., Branco, T., and
Staras, K. (2012). Recruitment
of resting vesicles into recy-
cling pools supports NMDA
receptor-dependent synaptic
potentiation in cultured hip-
pocampal neurons. J. Physiol. 590,
1585–1597. doi: 10.1113/jphysiol.
2011.226688
Rieke, F., and Schwartz, E. A. (1994).
A cGMP-gated current can control
exocytosis at cone synapses. Neuron
13, 863–873. doi: 10.1016/0896-
6273(94)90252-6
Romberg, C., Raffel, J., Martin, L.,
Sprengel, R., Seeburg, P. H.,
Rawlins, J. N., et al. (2009).
Induction and expression of GluA1
(GluR-A)-independent LTP in the
hippocampus. Eur. J. Neurosci. 29,
1141–1152. doi: 10.1111/j.1460-
9568.2009.06677.x
Roy, B., Halvey, E. J., and Garthwaite,
J. (2008). An enzyme-linked
receptor mechanism for nitric
oxide-activated guanylyl cyclase.
J. Biol. Chem. 283, 18841–18851.
doi: 10.1074/jbc.M801712200
Russwurm, M., Wittau, N., and
Koesling, D. (2001). Guanylyl
cyclase/PSD-95 interaction:
targeting of the nitric oxide-
sensitive alpha2beta1 guanylyl
cyclase to synaptic mem-
branes. J. Biol. Chem. 276,
44647–44652. doi: 10.1074/jbc.
M105587200
Saha, R. N., and Pahan, K. (2006).
Signals for the induction of nitric
oxide synthase in astrocytes.
Neurochem. Int. 49, 154–163. doi:
10.1016/j.neuint.2006.04.007
Sammut, S., Bray, K. E., and West,
A. R. (2007a). Dopamine D2
receptor-dependent modulation
of striatal NO synthase activity.
Psychopharmacology (Berl.) 191,
Frontiers in Cellular Neuroscience www.frontiersin.org October 2013 | Volume 7 | Article 190 | 17
Hardingham et al. Nitric oxide and pre-synaptic plasticity
793–803. doi: 10.1007/s00213-006-
0681-z
Sammut, S., Park, D. J., and
West, A. R. (2007b). Frontal
cortical afferents facilitate stri-
atal nitric oxide transmission
in vivo via a NMDA receptor
and neuronal NOS-dependent
mechanism. J. Neurochem. 103,
1145–1156. doi: 10.1111/j.1471-
4159.2007.04811.x
Sammut, S., Dec, A., Mitchell, D.,
Linardakis, J., Ortiguela, M., and
West, A. R. (2006). Phasic dopamin-
ergic transmission increases NO
efflux in the rat dorsal striatum via
a neuronal NOS and a dopamine
D(1/5) receptor-dependent mech-
anism. Neuropsychopharmacology
31, 493–505. doi: 10.1038/sj.npp.
1300826
Sammut, S., and West, A. R.
(2008). Acute cocaine adminis-
tration increases NO efflux in
the rat prefrontal cortex via a
neuronal NOS-dependent mech-
anism. Synapse 62, 710–713. doi:
10.1002/syn.20537
Santolini, J., Adak, S., Curran, C.
M., and Stuehr, D. J. (2001). A
kinetic simulation model that
describes catalysis and regula-
tion in nitric-oxide synthase.
J. Biol. Chem. 276, 1233–1243. doi:
10.1074/jbc.M006858200
Sato, M., Nakajima, T., Goto, M., and
Umezawa, Y. (2006). Cell-based
indicator to visualize picomolar
dynamics of nitric oxide release
from living cells. Anal. Chem.
78, 8175–8182. doi: 10.1021/
ac061791b
Schlossmann, J., and Hofmann,
F. (2005). cGMP-dependent
protein kinases in drug dis-
covery. Drug Discov. Today 10,
627–634. doi: 10.1016/S1359-6446
(05)03406-9
Schuman, E. M., and Madison, D.
V. (1991). A requirement for the
intercellular messenger nitric oxide
in long-term potentiation. Science
254, 1503–1506. doi: 10.1126/sci-
ence.1720572
Serulle, Y., Arancio, O., and Ziff, E. B.
(2008). A role for cGMP-dependent
protein kinase II in AMPA receptor
trafficking and synaptic plasticity.
Channels (Austin) 2, 230–232. doi:
10.4161/chan.2.4.6391
Shibuki, K., and Kimura, S. (1997).
Dynamic properties of nitric oxide
release from parallel fibres in rat
cerebellar slices. J. Physiol. 498
(Pt 2), 443–452.
Sjostrom, P. J., Turrigiano, G. G.,
and Nelson, S. B. (2007). Multiple
forms of long-term plasticity at
unitary neocortical layer 5 synapses.
Neuropharmacology 52, 176–184.
doi: 10.1016/j.neuropharm.
2006.07.021
Stanton, P. K., Winterer, J., Bailey, C. P.,
Kyrozis, A., Raginov, I., Laube, G.,
et al. (2003). Long-term depression
of presynaptic release from the read-
ily releasable vesicle pool induced
by NMDA receptor-dependent ret-
rograde nitric oxide. J. Neurosci. 23,
5936–5944.
Stanton, P. K., Winterer, J., Zhang, X.
L., and Muller, W. (2005). Imaging
LTP of presynaptic release of FM1-
43 from the rapidly recycling vesi-
cle pool of Schaffer collateral-CA1
synapses in rat hippocampal slices.
Eur. J. Neurosci. 22, 2451–2461. doi:
10.1111/j.1460-9568.2005.04437.x
Steinert, J. R., Chernova, T., and
Forsythe, I. D. (2010). Nitric
oxide signaling in brain func-
tion, dysfunction, and dementia.
Neuroscientist 16, 435–452. doi:
10.1177/1073858410366481
Steinert, J. R., Kopp-Scheinpflug, C.,
Baker, C., Challiss, R. A., Mistry,
R., Haustein, M. D., et al. (2008).
Nitric oxide is a volume trans-
mitter regulating postsynaptic
excitability at a glutamatergic
synapse. Neuron 60, 642–656. doi:
10.1016/j.neuron.2008.08.025
Szabadits, E., Cserep, C., Ludanyi,
A., Katona, I., Gracia-Llanes,
J., Freund, T. F., et al. (2007).
Hippocampal GABAergic synapses
possess the molecular machin-
ery for retrograde nitric oxide
signaling. J. Neurosci. 27,
8101–8111. doi: 10.1523/
JNEUROSCI.1912-07.2007
Tanda, K., Nishi, A., Matsuo, N.,
Nakanishi, K., Yamasaki, N.,
Sugimoto, T., et al. (2009).
Abnormal social behavior, hyper-
activity, impaired remote spatial
memory, and increased D1-
mediated dopaminergic signaling
in neuronal nitric oxide synthase
knockout mice. Mol. Brain 2, 19.
doi: 10.1186/1756-6606-2-19
Taniguchi, H., He, M., Wu, P., Kim,
S., Paik, R., Sugino, K., et al.
(2011). A resource of Cre driver
lines for genetic targeting of
GABAergic neurons in cerebral
cortex. Neuron 71, 995–1013. doi:
10.1016/j.neuron.2011.07.026
Valtschanoff, J. G., and Weinberg, R. J.
(2001). Laminar organization of the
NMDA receptor complex within the
postsynaptic density. J. Neurosci. 21,
1211–1217.
Volgushev,M., Balaban, P., Chistiakova,
M., and Eysel, U. T. (2000).
Retrograde signalling with nitric
oxide at neocortical synapses.
Eur. J. Neurosci. 12, 4255–4267.
doi: 10.1046/j.0953-816X.2000.
01322.x
Wakatsuki, H., Gomi, H., Kudoh, M.,
Kimura, S., Takahashi, K., Takeda,
M., et al. (1998). Layer-specific
NO dependence of long-term
potentiation and biased NO
release in layer V in the rat audi-
tory cortex. J. Physiol. 513(Pt 1),
71–81. doi: 10.1111/j.1469-7793.
1998.071by.x
Wall, M. J. (2003). Endogenous nitric
oxide modulates GABAergic trans-
mission to granule cells in adult
rat cerebellum. Eur. J. Neurosci.
18, 869–878. doi: 10.1046/j.1460-
9568.2003.02822.x
Wallace, H., and Fox, K. (1999). The
effect of vibrissa deprivation pattern
on the form of plasticity induced in
rat barrel cortex. Somatosens. Mot.
Res. 16, 122–138. doi: 10.1080/0899
0229970564
Wang, H. G., Lu, F. M., Jin, I., Udo,
H., Kandel, E. R., De Vente,
J., et al. (2005). Presynaptic
and postsynaptic roles of NO,
cGK, and RhoA in long-lasting
potentiation and aggregation of
synaptic proteins. Neuron 45,
389–403. doi: 10.1016/j.neuron.
2005.01.011
Wehr, M., and Zador, A. M. (2003).
Balanced inhibition underlies
tuning and sharpens spike tim-
ing in auditory cortex. Nature
426, 442–446. doi: 10.1038/
nature02116
Wehr, M., and Zador, A. M. (2005).
Synaptic mechanisms of forward
suppression in rat auditory cor-
tex. Neuron 47, 437–445. doi:
10.1016/j.neuron.2005.06.009
Weitzdoerfer, R., Hoeger, H.,
Engidawork, E., Engelmann,
M., Singewald, N., Lubec, G.,
et al. (2004). Neuronal nitric oxide
synthase knock-out mice show
impaired cognitive performance.
Nitric Oxide 10, 130–140. doi:
10.1016/j.niox.2004.03.007
Wendland, B., Schweizer, F. E., Ryan,
T. A., Nakane, M., Murad, F.,
Scheller, R. H., et al. (1994).
Existence of nitric oxide synthase
in rat hippocampal pyrami-
dal cells. Proc. Natl. Acad.
Sci. U.S.A. 91, 2151–2155. doi:
10.1073/pnas.91.6.2151
West, A. R., Galloway, M. P., and Grace,
A. A. (2002). Regulation of stri-
atal dopamine neurotransmission
by nitric oxide: effector pathways
and signaling mechanisms. Synapse
44, 227–245. doi: 10.1002/syn.10076
Wildemann, B., and Bicker, G.
(1999). Nitric oxide and cyclic
GMP induce vesicle release
at Drosophila neuromuscular
junction. J. Neurobiol. 39, 337–346.
doi: 10.1002/(SICI)1097-4695(199
90605)39:3<337::AID-NEU1>3.0.
CO;2-9
Wilent,W. B., and Contreras, D. (2005).
Dynamics of excitation and inhi-
bition underlying stimulus selec-
tivity in rat somatosensory cortex.
Nat. Neurosci. 8, 1364–1370. doi:
10.1038/nn1545
Wiseman, D. A., Kalwat, M. A.,
and Thurmond, D. C. (2011).
Stimulus-induced S-nitrosylation of
Syntaxin 4 impacts insulin granule
exocytosis. J. Biol. Chem. 286,
16344–16354. doi: 10.1074/jbc.
M110.214031
Wood, K. C., Batchelor, A. M., Bartus,
K., Harris, K. L., Garthwaite, G.,
Vernon, J., et al. (2011). Picomolar
nitric oxide signals from central
neurons recorded using ultra-
sensitive detector cells. J. Biol.
Chem. 286, 43172–43181. doi:
10.1074/jbc.M111.289777
Wu, W. C., Wang, Y., Kao, L. S.,
Tang, F. I., and Chai, C. Y. (2002).
Nitric oxide reduces blood pres-
sure in the nucleus tractus soli-
tarius: a real time electrochem-
ical study. Brain. Res. Bull. 57,
171–177. doi: 10.1016/S0361-9230
(01)00737-7
Wu, W. C., Wang, Y., Su, C. K.,
and Chai, C. Y. (2001). The
nNOS/cGMP signal transducing
system is involved in the cardio-
vascular responses induced by
activation of NMDA receptors in
the rostral ventrolateral medulla of
cats. Neurosci. Lett. 310, 121–124.
doi: 10.1016/S0304-3940(01)
02100-0
Xue, J. G., Masuoka, T., Gong,
X. D., Chen, K. S., Yanagawa,
Y., Law, S. K., et al. (2011).
NMDA receptor activation
enhances inhibitory GABAergic
transmission onto hippocampal
pyramidal neurons via presynaptic
and postsynaptic mechanisms.
J. Neurophysiol. 105, 2897–2906.
doi: 10.1152/jn.00287.2010
Yang, Q., Chen, S. R., Li, D. P.,
and Pan, H. L. (2007). Kv1.1/1.2
channels are downstream effec-
tors of nitric oxide on synaptic
GABA release to preautonomic
neurons in the paraventricular
nucleus. Neuroscience 149, 315–327.
doi: 10.1016/j.neuroscience.2007.
08.007
Yildiz Akar, F., Celikyurt, I. K., Ulak,
G., and Mutlu, O. (2009). Effects
of L-arginine on 7-nitroindazole-
induced reference and working
memory performance of rats.
Pharmacology 84, 211–218. doi:
10.1159/000235997
Frontiers in Cellular Neuroscience www.frontiersin.org October 2013 | Volume 7 | Article 190 | 18
Hardingham et al. Nitric oxide and pre-synaptic plasticity
Zhou, L., Li, F., Xu, H. B., Luo,
C. X., Wu, H. Y., Zhu, M. M.,
et al. (2010). Treatment of cerebral
ischemia by disrupting ischemia-
induced interaction of nNOS with
PSD-95. Nat. Med. 16, 1439–1443.
doi: 10.1038/nm.2245
Zhou, L., and Zhu, D. Y. (2009).
Neuronal nitric oxide synthase:
structure, subcellular localiza-
tion, regulation, and clinical
implications. Nitric Oxide 20,
223–230. doi: 10.1016/j.niox.2009.
03.001
Zou, L. B., Yamada, K., Tanaka, T.,
Kameyama, T., and Nabeshima,
T. (1998). Nitric oxide synthase
inhibitors impair reference memory
formation in a radial arm maze
task in rats. Neuropharmacology 37,
323–330. doi: 10.1016/S0028-3908
(98)00042-2
Conflict of Interest Statement: The
authors declare that the research
was conducted in the absence of any
commercial or financial relationships
that could be construed as a potential
conflict of interest.
Received: 13 August 2013; paper pending
published: 11 September 2013; accepted:
05 October 2013; published online: 31
October 2013.
Citation: Hardingham N, Dachtler J and
Fox K (2013) The role of nitric oxide
in pre-synaptic plasticity and homeosta-
sis. Front. Cell. Neurosci. 7:190. doi:
10.3389/fncel.2013.00190
This article was submitted to the journal
Frontiers in Cellular Neuroscience.
Copyright © 2013 Hardingham,
Dachtler and Fox. This is an open-access
article distributed under the terms of
the Creative Commons Attribution
License (CC BY). The use, distribu-
tion or reproduction in other forums
is permitted, provided the original
author(s) or licensor are credited and
that the original publication in this
journal is cited, in accordance with
accepted academic practice. No use,
distribution or reproduction is permit-
ted which does not comply with these
terms.
Frontiers in Cellular Neuroscience www.frontiersin.org October 2013 | Volume 7 | Article 190 | 19
